Section 5 SE Tables - Results from the 2024 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

250602

Table 5.1C – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER	768	805	97	91	756	795	199	191	702	756
DRUGS	615	655	88	85	601	640	176	175	548	603
Marijuana	504	540	74	73	494	529	169	169	440	486
Cocaine	124	125	16	6	123	124	28	40	119	117
Heroin	94	78	*	6	94	78	7	10	94	78
Hallucinogens	60	64	13	21	58	60	24	22	48	56
Inhalants	52	57	17	21	50	53	10	21	49	48
Methamphetamine	179	154	10	8	179	153	16	21	178	151
Prescription Psychotherapeutics	332	345	49	49	326	338	59	59	319	334
Pain Relievers	299	294	36	34	296	292	46	42	289	289
Prescription Opioids	276	281	27	33	273	279	43	39	266	277
Stimulants	129	125	34	31	122	120	37	45	114	110
Tranquilizers or Sedatives	167	169	22	23	164	167	33	31	160	165
Tranquilizers	145	135	18	20	143	134	29	28	139	133
Sedatives	105	108	16	13	104	107	18	20	102	105
Opioids¹	285	286	27	34	281	283	43	41	273	281
Central Nervous System Stimulants	243	224	35	32	238	221	45	62	233	210
ALCOHOL	579	582	59	59	574	578	164	149	543	555
BOTH DRUGS AND ALCOHOL	298	306	35	46	295	298	103	107	274	277
DRUGS ONLY (NO ALCOHOL USE DISORDER)	505	537	82	72	494	531	147	140	451	504
ALCOHOL ONLY (NO DRUG USE DISORDER)	514	521	47	36	509	520	125	122	487	504
NO SUBSTANCE USE DISORDER	768	805	97	91	756	795	199	191	702	756
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.1D – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2023 and 2024
Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER	0.27	0.28	0.37	0.35	0.29	0.30	0.59	0.55	0.31	0.33
DRUGS	0.22	0.23	0.34	0.33	0.23	0.24	0.52	0.50	0.25	0.27
Marijuana	0.18	0.19	0.28	0.28	0.19	0.20	0.50	0.48	0.20	0.21
Cocaine	0.04	0.04	0.06	0.02	0.05	0.05	0.08	0.11	0.05	0.05
Heroin	0.03	0.03	*	0.02	0.04	0.03	0.02	0.03	0.04	0.03
Hallucinogens	0.02	0.02	0.05	0.08	0.02	0.02	0.07	0.06	0.02	0.02
Inhalants	0.02	0.02	0.07	0.08	0.02	0.02	0.03	0.06	0.02	0.02
Methamphetamine	0.06	0.05	0.04	0.03	0.07	0.06	0.05	0.06	0.08	0.07
Prescription Psychotherapeutics	0.12	0.12	0.19	0.19	0.13	0.13	0.17	0.17	0.14	0.15
Pain Relievers	0.11	0.10	0.14	0.13	0.11	0.11	0.14	0.12	0.13	0.13
Prescription Opioids	0.10	0.10	0.10	0.13	0.11	0.11	0.13	0.11	0.12	0.12
Stimulants	0.05	0.04	0.13	0.12	0.05	0.05	0.11	0.13	0.05	0.05
Tranquilizers or Sedatives	0.06	0.06	0.09	0.09	0.06	0.06	0.10	0.09	0.07	0.07
Tranquilizers	0.05	0.05	0.07	0.08	0.06	0.05	0.09	0.08	0.06	0.06
Sedatives	0.04	0.04	0.06	0.05	0.04	0.04	0.05	0.06	0.05	0.05
Opioids¹	0.10	0.10	0.10	0.13	0.11	0.11	0.13	0.12	0.12	0.12
Central Nervous System Stimulants	0.09	0.08	0.14	0.12	0.09	0.08	0.13	0.18	0.10	0.09
ALCOHOL	0.20	0.20	0.23	0.23	0.22	0.22	0.48	0.43	0.24	0.24
BOTH DRUGS AND ALCOHOL	0.11	0.11	0.14	0.18	0.11	0.11	0.30	0.31	0.12	0.12
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.18	0.19	0.32	0.28	0.19	0.20	0.43	0.40	0.20	0.22
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.18	0.18	0.18	0.14	0.20	0.20	0.37	0.35	0.22	0.22
NO SUBSTANCE USE DISORDER	0.27	0.28	0.37	0.35	0.29	0.30	0.59	0.55	0.31	0.33
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.1P – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Substance	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
SUBSTANCE USE DISORDER	0.4042	0.2155	0.4690	0.1214	0.6943
DRUGS	0.5217	0.5438	0.4621	0.7846	0.4000
Marijuana	0.1268	0.9622	0.1185	0.2845	0.0416
Cocaine	0.7003	0.0657	0.8278	0.0802	0.4491
Heroin	0.3968	*	0.3511	0.1950	0.2872
Hallucinogens	0.9776	0.3484	0.7590	0.3035	0.9286
Inhalants	0.6099	0.8227	0.6356	0.0806	0.9655
Methamphetamine	0.2763	0.2843	0.3018	0.3852	0.2529
Prescription Psychotherapeutics	0.4133	0.2683	0.4985	0.8550	0.4692
Pain Relievers	0.2543	0.5346	0.2780	0.3076	0.3431
Prescription Opioids	0.6326	0.4500	0.5654	0.4864	0.6331
Stimulants	0.5867	0.2399	0.3850	0.1428	0.6872
Tranquilizers or Sedatives	0.3940	0.5052	0.4385	0.8099	0.4002
Tranquilizers	0.1472	0.8568	0.1501	0.5120	0.1071
Sedatives	0.6350	0.1708	0.7680	0.6922	0.7113
Opioids¹	0.4561	0.3981	0.3926	0.6976	0.4203
Central Nervous System Stimulants	0.6849	0.2094	0.8177	0.0175	0.3991
ALCOHOL	0.0715	0.8354	0.0609	0.2900	0.0957
BOTH DRUGS AND ALCOHOL	0.8675	0.0600	0.9084	0.4139	0.6358
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.4946	0.0917	0.3422	0.3435	0.2050
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.0349	0.1154	0.0433	0.0411	0.1151
NO SUBSTANCE USE DISORDER	0.4042	0.2155	0.4690	0.1214	0.6943
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.2C – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Standard Errors of Numbers in Thousands, 2023 and 2024
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Severity Level
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Mild Substance Use Disorder (2023)	Mild Substance Use Disorder (2024)	Moderate Substance Use Disorder (2023)	Moderate Substance Use Disorder (2024)	Severe Substance Use Disorder (2023)	Severe Substance Use Disorder (2024)
SUBSTANCE USE DISORDER	768	805	575	581	353	380	355	346
DRUGS	615	655	437	459	266	300	255	267
Marijuana	504	540	354	382	223	269	176	175
Cocaine	124	125	66	70	63	47	83	84
Heroin	94	78	27	24	26	37	86	66
Hallucinogens	60	64	49	55	28	27	6	15
Inhalants	52	57	37	46	11	23	35	23
Methamphetamine	179	154	91	46	71	61	139	130
Prescription Psychotherapeutics	332	345	287	294	150	125	97	116
Pain Relievers	299	294	258	250	137	104	82	103
Prescription Opioids	276	281	245	237	99	102	82	102
Stimulants	129	125	115	96	41	61	37	46
Tranquilizers or Sedatives	167	169	140	147	68	51	56	63
Tranquilizers	145	135	120	113	63	40	49	58
Sedatives	105	108	92	95	37	41	38	32
Opioids¹	285	286	239	235	102	107	116	114
Central Nervous System Stimulants	243	224	155	121	89	95	162	157
ALCOHOL	579	582	450	444	268	264	274	243
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.2D – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Standard Errors of Percentages, 2023 and 2024
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Severity Level
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Mild Substance Use Disorder (2023)	Mild Substance Use Disorder (2024)	Moderate Substance Use Disorder (2023)	Moderate Substance Use Disorder (2024)	Severe Substance Use Disorder (2023)	Severe Substance Use Disorder (2024)
SUBSTANCE USE DISORDER	0.27	0.28	0.20	0.20	0.12	0.13	0.13	0.12
DRUGS	0.22	0.23	0.15	0.16	0.09	0.10	0.09	0.09
Marijuana	0.18	0.19	0.12	0.13	0.08	0.09	0.06	0.06
Cocaine	0.04	0.04	0.02	0.02	0.02	0.02	0.03	0.03
Heroin	0.03	0.03	0.01	0.01	0.01	0.01	0.03	0.02
Hallucinogens	0.02	0.02	0.02	0.02	0.01	0.01	<0.01	0.01
Inhalants	0.02	0.02	0.01	0.02	<0.01	0.01	0.01	0.01
Methamphetamine	0.06	0.05	0.03	0.02	0.03	0.02	0.05	0.04
Prescription Psychotherapeutics	0.12	0.12	0.10	0.10	0.05	0.04	0.03	0.04
Pain Relievers	0.11	0.10	0.09	0.09	0.05	0.04	0.03	0.04
Prescription Opioids	0.10	0.10	0.09	0.08	0.04	0.04	0.03	0.04
Stimulants	0.05	0.04	0.04	0.03	0.01	0.02	0.01	0.02
Tranquilizers or Sedatives	0.06	0.06	0.05	0.05	0.02	0.02	0.02	0.02
Tranquilizers	0.05	0.05	0.04	0.04	0.02	0.01	0.02	0.02
Sedatives	0.04	0.04	0.03	0.03	0.01	0.01	0.01	0.01
Opioids¹	0.10	0.10	0.08	0.08	0.04	0.04	0.04	0.04
Central Nervous System Stimulants	0.09	0.08	0.05	0.04	0.03	0.03	0.06	0.05
ALCOHOL	0.20	0.20	0.16	0.15	0.09	0.09	0.10	0.08
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.2P – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Severity Level
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Mild Substance Use Disorder (2023)	Mild Substance Use Disorder (2024)	Moderate Substance Use Disorder (2023)	Moderate Substance Use Disorder (2024)	Severe Substance Use Disorder (2023)	Severe Substance Use Disorder (2024)
SUBSTANCE USE DISORDER	0.4042		0.5173		0.7981		0.6100
DRUGS	0.5217		0.9171		0.1834		0.9204
Marijuana	0.1268		0.4451		0.1103		0.5715
Cocaine	0.7003		0.4873		0.4858		0.5043
Heroin	0.3968		0.7622		0.5768		0.2958
Hallucinogens	0.9776		0.6335		0.7338		0.2239
Inhalants	0.6099		0.9292		0.0601		0.8161
Methamphetamine	0.2763		0.0122		0.8493		0.9385
Prescription Psychotherapeutics	0.4133		0.5173		0.5124		0.9512
Pain Relievers	0.2543		0.3488		0.3709		0.8780
Prescription Opioids	0.6326		0.6185		0.8333		0.9179
Stimulants	0.5867		0.7338		0.1651		0.4312
Tranquilizers or Sedatives	0.3940		0.6665		0.1044		0.7293
Tranquilizers	0.1472		0.2765		0.0491		0.5182
Sedatives	0.6350		0.5616		0.8009		0.8711
Opioids¹	0.4561		0.6601		0.8914		0.4022
Central Nervous System Stimulants	0.6849		0.2869		0.3078		0.8104
ALCOHOL	0.0715		0.3028		0.2101		0.3595
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.3C – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Drug Use Disorder (2023)	Drug Use Disorder (2024)	Alcohol Use Disorder (2023)	Alcohol Use Disorder (2024)	Substance Use Disorder (2023)	Substance Use Disorder (2024)
TOTAL	615	655	579	582	768	805
12-20¹	161	133	120	100	194	152
21 or Older¹	670	704	640	650	932	967
12-17	88	85	59	59	97	91
12-13	25	31	11	16	27	33
14-15	57	40	38	28	65	43
16-17	68	70	46	50	77	77
18 or Older	601	640	574	578	756	795
18-25	176	175	164	149	199	191
18-20	119	99	99	81	148	119
21-25	166	173	162	155	217	211
26 or Older	548	603	543	555	702	756
26-49	350	377	368	370	436	488
26-29	193	198	178	167	246	245
30-34	166	183	182	169	227	235
35-39	191	181	175	191	256	244
40-44	131	145	189	177	219	217
45-49	148	146	149	152	206	206
50 or Older	407	411	408	425	532	552
50-54	195	195	203	218	264	284
55-59	176	186	180	212	246	278
60-64	225	222	214	183	285	274
65 or Older	227	212	240	227	308	299
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.3D – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Drug Use Disorder (2023)	Drug Use Disorder (2024)	Alcohol Use Disorder (2023)	Alcohol Use Disorder (2024)	Substance Use Disorder (2023)	Substance Use Disorder (2024)
TOTAL	0.22	0.23	0.20	0.20	0.27	0.28
12-20¹	0.37	0.32	0.29	0.25	0.42	0.36
21 or Older¹	0.24	0.25	0.23	0.23	0.30	0.31
12-17	0.34	0.33	0.23	0.23	0.37	0.35
12-13	0.31	0.37	0.14	0.20	0.33	0.40
14-15	0.58	0.45	0.41	0.32	0.65	0.48
16-17	0.73	0.72	0.51	0.54	0.80	0.78
18 or Older	0.23	0.24	0.22	0.22	0.29	0.30
18-25	0.52	0.50	0.48	0.43	0.59	0.55
18-20	0.83	0.72	0.74	0.59	0.97	0.82
21-25	0.62	0.66	0.60	0.60	0.71	0.72
26 or Older	0.25	0.27	0.24	0.24	0.31	0.33
26-49	0.34	0.36	0.36	0.35	0.42	0.46
26-29	0.97	0.98	0.85	0.85	1.10	1.12
30-34	0.67	0.71	0.74	0.67	0.87	0.85
35-39	0.71	0.72	0.68	0.74	0.88	0.90
40-44	0.60	0.64	0.81	0.74	0.91	0.89
45-49	0.73	0.72	0.77	0.72	1.01	0.93
50 or Older	0.34	0.34	0.34	0.35	0.44	0.45
50-54	1.00	0.95	1.04	1.05	1.31	1.32
55-59	0.83	0.92	0.84	1.01	1.12	1.29
60-64	0.94	0.95	0.88	0.77	1.14	1.11
65 or Older	0.39	0.35	0.41	0.38	0.53	0.50
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.3P – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Drug Use Disorder (2023)	Alcohol Use Disorder (2023)	Substance Use Disorder (2023)
TOTAL	0.5217	0.0715	0.4042
12-20¹	0.1775	0.3540	0.0151
21 or Older¹	0.3216	0.0925	0.6925
12-17	0.5438	0.8354	0.2155
12-13	0.7411	0.3714	0.7077
14-15	0.0128	0.2467	0.0022
16-17	0.4688	0.4263	0.7740
18 or Older	0.4621	0.0609	0.4690
18-25	0.7846	0.2900	0.1214
18-20	0.1319	0.1196	0.0121
21-25	0.4554	0.7878	0.8973
26 or Older	0.4000	0.0957	0.6943
26-49	0.1943	0.0251	0.5853
26-29	0.4036	0.2371	0.9561
30-34	0.4794	0.0058	0.1398
35-39	0.5911	0.5219	0.5357
40-44	0.4494	0.1970	0.5130
45-49	0.7265	0.7254	0.7412
50 or Older	0.9786	0.7814	0.8775
50-54	0.9294	0.3868	0.4172
55-59	0.4158	0.5933	0.3865
60-64	0.6596	0.6099	0.7664
65 or Older	0.9005	0.7260	0.9192
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.4C – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	615	655	88	85	601	640	176	175	548	603
SEX
Male	462	497	56	57	455	488	133	125	418	468
Female	347	368	68	64	336	360	106	120	305	328
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	563	599	66	71	555	589	147	147	517	556
AIAN	47	34	4	3	46	34	10	11	45	29
Asian	131	116	15	21	130	115	36	33	123	110
Black or African American	247	228	31	30	238	222	75	74	221	199
NHPI	*	25	1	<1	*	25	*	*	*	23
White	447	510	61	63	503	571	147	137	454	533
Two or More Races	81	106	16	15	80	106	37	35	72	99
Hispanic or Latino	226	231	55	47	221	228	91	94	195	203
EDUCATION LEVEL
< High School	da	da	da	da	172	186	53	55	167	182
High School Graduate	da	da	da	da	375	356	112	109	392	360
Some College/Associate’s Degree	da	da	da	da	348	340	152	136	317	347
College Graduate	da	da	da	da	236	264	58	80	246	270
EMPLOYMENT STATUS
Full-Time	da	da	da	da	432	412	121	136	395	381
Part-Time	da	da	da	da	179	210	102	100	141	176
Unemployed	da	da	da	da	169	164	64	68	154	144
Other¹	da	da	da	da	396	401	84	77	380	391
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.4D – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.22	0.23	0.34	0.33	0.23	0.24	0.52	0.50	0.25	0.27
SEX
Male	0.33	0.35	0.42	0.43	0.36	0.38	0.78	0.71	0.39	0.42
Female	0.24	0.25	0.53	0.50	0.25	0.27	0.62	0.69	0.27	0.28
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.24	0.26	0.34	0.37	0.26	0.27	0.57	0.56	0.28	0.29
AIAN	3.15	2.26	1.56	1.37	3.76	2.65	5.85	5.30	4.21	2.63
Asian	0.73	0.60	1.04	1.31	0.79	0.65	1.52	1.31	0.87	0.73
Black or African American	0.63	0.56	0.78	0.81	0.68	0.61	1.35	1.26	0.77	0.67
NHPI	*	2.00	0.96	0.55	*	2.15	*	*	*	2.35
White	0.26	0.30	0.45	0.47	0.28	0.32	0.67	0.65	0.29	0.34
Two or More Races	1.31	1.43	1.65	1.37	1.53	1.69	2.78	2.64	1.74	2.02
Hispanic or Latino	0.43	0.42	0.80	0.68	0.49	0.48	1.10	1.07	0.53	0.52
EDUCATION LEVEL
< High School	da	da	da	da	0.70	0.77	1.30	1.43	0.79	0.86
High School Graduate	da	da	da	da	0.54	0.51	0.82	0.78	0.61	0.58
Some College/Associate’s Degree	da	da	da	da	0.45	0.44	0.95	0.85	0.47	0.49
College Graduate	da	da	da	da	0.27	0.29	0.92	1.19	0.28	0.30
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.32	0.31	0.77	0.81	0.33	0.33
Part-Time	da	da	da	da	0.54	0.60	1.01	0.99	0.60	0.70
Unemployed	da	da	da	da	1.32	1.10	1.71	1.56	1.73	1.40
Other¹	da	da	da	da	0.39	0.39	0.86	0.86	0.42	0.42
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.4P – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.5217	0.5438	0.4621	0.7846	0.4000
SEX
Male	0.5028	0.4989	0.5622	0.4585	0.4170
Female	0.8109	0.1677	0.6014	0.6673	0.6923
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5104	0.9137	0.5204	0.7344	0.4432
AIAN	0.2525	0.9808	0.2219	1.0000	0.1880
Asian	0.6081	0.9691	0.6000	0.6801	0.6652
Black or African American	0.9147	0.9113	0.9152	0.7594	1.0000
NHPI	*	0.3089	*	*	*
White	0.2155	0.6716	0.2321	0.9730	0.2095
Two or More Races	0.2702	0.3232	0.1828	0.8108	0.1355
Hispanic or Latino	0.8774	0.2202	0.6656	0.9416	0.6710
EDUCATION LEVEL
< High School	da	da	0.9385	0.9859	0.9404
High School Graduate	da	da	0.6280	0.1414	0.3994
Some College/Associate’s Degree	da	da	0.4766	0.9910	0.4179
College Graduate	da	da	0.7173	0.1263	0.9610
EMPLOYMENT STATUS
Full-Time	da	da	0.9452	0.8267	0.9735
Part-Time	da	da	0.7372	0.0908	0.2190
Unemployed	da	da	0.4524	0.7971	0.4890
Other¹	da	da	0.2895	0.3403	0.3535
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.5C – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	504	540	74	73	494	529	169	169	440	486
SEX
Male	386	417	47	48	381	410	128	120	339	383
Female	257	299	57	54	249	291	102	116	222	257
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	471	492	54	58	465	485	143	143	416	448
AIAN	41	33	3	2	40	33	8	10	39	27
Asian	61	74	13	14	60	73	34	31	44	66
Black or African American	200	205	26	25	194	200	74	72	172	178
NHPI	*	24	*	<1	*	24	*	*	*	*
White	370	410	45	51	395	448	140	129	350	410
Two or More Races	76	91	15	12	75	90	37	34	66	83
Hispanic or Latino	172	197	49	44	166	190	89	90	142	161
EDUCATION LEVEL
< High School	da	da	da	da	120	138	51	53	105	125
High School Graduate	da	da	da	da	285	303	107	104	283	307
Some College/Associate’s Degree	da	da	da	da	281	297	147	129	238	280
College Graduate	da	da	da	da	194	205	56	78	195	198
EMPLOYMENT STATUS
Full-Time	da	da	da	da	362	359	119	131	329	328
Part-Time	da	da	da	da	157	180	99	96	119	142
Unemployed	da	da	da	da	134	151	62	65	114	131
Other¹	da	da	da	da	262	287	80	70	248	278
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Marijuana use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.5D – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.18	0.19	0.28	0.28	0.19	0.20	0.50	0.48	0.20	0.21
SEX
Male	0.28	0.30	0.35	0.36	0.30	0.32	0.75	0.69	0.31	0.35
Female	0.18	0.20	0.45	0.43	0.19	0.22	0.60	0.67	0.19	0.22
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.20	0.21	0.28	0.31	0.22	0.23	0.55	0.55	0.22	0.24
AIAN	2.83	2.18	1.32	1.15	3.41	2.55	5.08	5.46	3.85	2.49
Asian	0.35	0.39	0.86	0.93	0.37	0.42	1.44	1.24	0.32	0.45
Black or African American	0.52	0.51	0.68	0.68	0.57	0.56	1.35	1.23	0.61	0.61
NHPI	*	1.94	*	0.55	*	2.09	*	*	*	*
White	0.22	0.24	0.34	0.39	0.23	0.26	0.64	0.62	0.24	0.27
Two or More Races	1.23	1.27	1.51	1.15	1.43	1.49	2.80	2.64	1.60	1.74
Hispanic or Latino	0.33	0.36	0.72	0.63	0.37	0.40	1.08	1.03	0.38	0.41
EDUCATION LEVEL
< High School	da	da	da	da	0.49	0.57	1.26	1.38	0.51	0.60
High School Graduate	da	da	da	da	0.41	0.43	0.78	0.75	0.45	0.50
Some College/Associate’s Degree	da	da	da	da	0.37	0.38	0.93	0.83	0.36	0.41
College Graduate	da	da	da	da	0.22	0.23	0.89	1.16	0.23	0.22
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.27	0.27	0.76	0.79	0.28	0.29
Part-Time	da	da	da	da	0.48	0.52	0.99	0.96	0.51	0.57
Unemployed	da	da	da	da	1.12	1.02	1.67	1.52	1.36	1.28
Other¹	da	da	da	da	0.27	0.29	0.83	0.80	0.28	0.31
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Marijuana use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.5P – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.1268	0.9622	0.1185	0.2845	0.0416
SEX
Male	0.1430	0.5670	0.1621	0.2554	0.0593
Female	0.4585	0.5863	0.3752	0.7400	0.2686
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1470	0.6451	0.1624	0.2738	0.0617
AIAN	0.9104	0.8250	0.8761	0.5779	0.7532
Asian	0.9113	0.5708	0.8207	0.6172	0.5976
Black or African American	0.1748	0.9791	0.1701	0.5225	0.0760
NHPI	*	*	*	*	*
White	0.2335	0.3100	0.2844	0.4258	0.1669
Two or More Races	0.6486	0.3212	0.4979	0.9490	0.4546
Hispanic or Latino	0.5651	0.5059	0.4396	0.8242	0.3295
EDUCATION LEVEL
< High School	da	da	0.3132	0.8754	0.2500
High School Graduate	da	da	0.1645	0.0320	0.0384
Some College/Associate’s Degree	da	da	0.4955	0.6478	0.3133
College Graduate	da	da	0.6460	0.1645	0.9871
EMPLOYMENT STATUS
Full-Time	da	da	0.2977	0.8575	0.2453
Part-Time	da	da	0.8998	0.0834	0.4099
Unemployed	da	da	0.7377	0.5760	0.4860
Other¹	da	da	0.1937	0.9647	0.1573
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Marijuana use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.6C – Prescription Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	276	281	27	33	273	279	43	39	266	277
SEX
Male	191	215	15	16	189	214	28	24	185	213
Female	193	186	22	29	192	184	29	31	190	184
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	246	266	23	27	243	265	37	33	239	262
AIAN	13	6	1	2	13	6	*	*	12	5
Asian	47	86	10	7	46	86	8	2	45	86
Black or African American	98	64	8	10	97	63	17	14	96	61
NHPI	*	6	*	*	*	6	*	*	*	5
White	195	236	19	25	199	239	28	28	195	238
Two or More Races	24	46	3	5	24	46	11	9	21	45
Hispanic or Latino	117	94	13	17	116	93	19	21	113	92
EDUCATION LEVEL
< High School	da	da	da	da	119	110	19	16	117	109
High School Graduate	da	da	da	da	189	180	20	29	192	181
Some College/Associate’s Degree	da	da	da	da	145	144	29	18	144	146
College Graduate	da	da	da	da	80	96	7	9	81	97
EMPLOYMENT STATUS
Full-Time	da	da	da	da	123	103	26	15	120	103
Part-Time	da	da	da	da	60	85	18	25	57	84
Unemployed	da	da	da	da	62	36	12	12	60	34
Other¹	da	da	da	da	230	240	24	23	229	240
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Prescription opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.6D – Prescription Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.10	0.10	0.10	0.13	0.11	0.11	0.13	0.11	0.12	0.12
SEX
Male	0.14	0.15	0.11	0.12	0.15	0.17	0.17	0.14	0.17	0.19
Female	0.13	0.13	0.17	0.23	0.15	0.14	0.17	0.18	0.16	0.16
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.11	0.11	0.12	0.14	0.11	0.12	0.14	0.12	0.13	0.14
AIAN	1.01	0.49	0.47	0.85	1.22	0.55	*	*	1.28	0.53
Asian	0.27	0.46	0.67	0.47	0.28	0.50	0.35	0.08	0.33	0.58
Black or African American	0.28	0.18	0.23	0.27	0.31	0.19	0.37	0.30	0.36	0.22
NHPI	*	0.50	*	*	*	0.53	*	*	*	0.52
White	0.11	0.14	0.15	0.19	0.12	0.15	0.16	0.16	0.14	0.17
Two or More Races	0.39	0.70	0.30	0.47	0.45	0.83	0.98	0.77	0.51	1.03
Hispanic or Latino	0.22	0.17	0.19	0.25	0.25	0.19	0.23	0.24	0.30	0.24
EDUCATION LEVEL
< High School	da	da	da	da	0.48	0.46	0.51	0.45	0.55	0.53
High School Graduate	da	da	da	da	0.27	0.26	0.18	0.24	0.32	0.31
Some College/Associate’s Degree	da	da	da	da	0.19	0.18	0.22	0.14	0.22	0.22
College Graduate	da	da	da	da	0.09	0.11	0.12	0.15	0.10	0.11
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.10	0.09	0.19	0.10	0.11	0.10
Part-Time	da	da	da	da	0.19	0.26	0.21	0.28	0.25	0.35
Unemployed	da	da	da	da	0.53	0.28	0.35	0.32	0.73	0.37
Other¹	da	da	da	da	0.24	0.24	0.28	0.28	0.26	0.27
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Prescription opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.6P – Prescription Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.6326	0.4500	0.5654	0.4864	0.6331
SEX
Male	0.7420	0.8577	0.7436	0.3098	0.8497
Female	0.7210	0.3246	0.6175	0.9974	0.6187
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5821	0.6578	0.5457	0.5378	0.5966
AIAN	0.0966	0.2526	0.0620	*	0.0750
Asian	0.4738	0.3268	0.3975	0.3068	0.3473
Black or African American	0.0332	0.9937	0.0317	0.8249	0.0313
NHPI	*	*	*	*	*
White	0.8629	0.4040	0.9325	0.7729	0.9019
Two or More Races	0.2428	0.8878	0.2388	0.9053	0.2108
Hispanic or Latino	0.9239	0.4442	0.9822	0.7444	0.9618
EDUCATION LEVEL
< High School	da	da	0.3070	0.5756	0.3366
High School Graduate	da	da	0.8416	0.1202	0.9770
Some College/Associate’s Degree	da	da	0.8915	0.0433	0.8307
College Graduate	da	da	0.6994	0.8068	0.7151
EMPLOYMENT STATUS
Full-Time	da	da	0.2906	0.0487	0.4873
Part-Time	da	da	0.2690	0.5846	0.3218
Unemployed	da	da	0.0364	0.8450	0.0270
Other¹	da	da	0.8844	0.9532	0.8682
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Prescription opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.7C – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	285	286	27	34	281	283	43	41	273	281
SEX
Male	198	220	15	16	196	219	28	25	191	218
Female	198	187	22	29	197	186	29	31	195	185
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	250	271	23	28	248	270	37	34	243	267
AIAN	13	7	1	2	13	6	*	*	12	5
Asian	47	86	10	7	46	86	8	2	45	86
Black or African American	100	67	8	10	99	67	17	14	97	65
NHPI	*	8	*	*	*	8	*	*	*	7
White	198	242	19	25	201	245	28	29	197	244
Two or More Races	24	46	3	5	24	46	11	9	21	45
Hispanic or Latino	122	95	13	17	121	94	19	21	117	93
EDUCATION LEVEL
< High School	da	da	da	da	120	111	18	16	119	110
High School Graduate	da	da	da	da	193	182	20	30	197	183
Some College/Associate’s Degree	da	da	da	da	150	145	29	19	149	148
College Graduate	da	da	da	da	82	96	7	9	83	97
EMPLOYMENT STATUS
Full-Time	da	da	da	da	130	104	27	15	127	103
Part-Time	da	da	da	da	61	86	18	25	59	84
Unemployed	da	da	da	da	62	40	12	14	61	38
Other¹	da	da	da	da	236	246	24	24	234	246
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.7D – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.10	0.10	0.10	0.13	0.11	0.11	0.13	0.12	0.12	0.12
SEX
Male	0.14	0.16	0.11	0.12	0.16	0.17	0.17	0.14	0.18	0.20
Female	0.14	0.13	0.17	0.23	0.15	0.14	0.17	0.18	0.17	0.16
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.11	0.12	0.12	0.14	0.12	0.13	0.14	0.13	0.13	0.14
AIAN	1.02	0.50	0.47	0.85	1.24	0.57	*	*	1.31	0.55
Asian	0.27	0.46	0.67	0.47	0.28	0.50	0.35	0.08	0.33	0.58
Black or African American	0.28	0.19	0.23	0.27	0.31	0.20	0.37	0.30	0.36	0.23
NHPI	*	0.63	*	*	*	0.67	*	*	*	0.71
White	0.12	0.14	0.15	0.19	0.12	0.15	0.16	0.16	0.14	0.17
Two or More Races	0.39	0.70	0.30	0.47	0.46	0.83	0.98	0.77	0.51	1.03
Hispanic or Latino	0.23	0.17	0.19	0.25	0.27	0.20	0.23	0.24	0.32	0.24
EDUCATION LEVEL
< High School	da	da	da	da	0.49	0.46	0.51	0.45	0.56	0.53
High School Graduate	da	da	da	da	0.28	0.26	0.18	0.24	0.33	0.31
Some College/Associate’s Degree	da	da	da	da	0.19	0.19	0.22	0.14	0.23	0.22
College Graduate	da	da	da	da	0.09	0.11	0.12	0.15	0.10	0.11
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.11	0.09	0.19	0.11	0.12	0.10
Part-Time	da	da	da	da	0.19	0.26	0.21	0.28	0.25	0.35
Unemployed	da	da	da	da	0.53	0.31	0.35	0.37	0.73	0.41
Other¹	da	da	da	da	0.24	0.25	0.28	0.28	0.27	0.27
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.7P – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4561	0.3981	0.3926	0.6976	0.4203
SEX
Male	0.6149	0.8577	0.6139	0.4101	0.6914
Female	0.5656	0.2784	0.4631	0.8118	0.4419
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4924	0.5802	0.4520	0.8016	0.4675
AIAN	0.0834	0.2526	0.0528	*	0.0644
Asian	0.4738	0.3268	0.3975	0.3068	0.3473
Black or African American	0.0208	0.9937	0.0193	0.8873	0.0182
NHPI	*	*	*	*	*
White	0.9131	0.3339	0.9931	0.9171	0.9973
Two or More Races	0.2723	0.8878	0.2680	0.9040	0.2384
Hispanic or Latino	0.7685	0.4442	0.6778	0.7448	0.7194
EDUCATION LEVEL
< High School	da	da	0.2699	0.5613	0.2976
High School Graduate	da	da	1.0000	0.0522	0.8297
Some College/Associate’s Degree	da	da	0.7895	0.0555	0.9524
College Graduate	da	da	0.5784	0.8068	0.5925
EMPLOYMENT STATUS
Full-Time	da	da	0.0939	0.0665	0.1758
Part-Time	da	da	0.3318	0.5694	0.3968
Unemployed	da	da	0.1111	0.4187	0.0629
Other¹	da	da	0.8148	0.9371	0.7965
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.8C – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	243	224	35	32	238	221	45	62	233	210
SEX
Male	197	182	22	25	194	180	34	45	190	173
Female	128	132	27	20	125	129	30	43	122	120
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	221	212	30	26	216	209	42	52	212	200
AIAN	29	7	2	1	29	6	3	1	28	6
Asian	24	29	3	13	23	26	11	14	21	22
Black or African American	78	55	4	1	77	55	10	17	77	53
NHPI	*	7	*	*	*	7	*	<1	*	7
White	198	186	30	23	198	188	39	48	194	181
Two or More Races	23	46	6	4	22	46	7	7	21	45
Hispanic or Latino	99	88	19	14	98	87	21	31	98	81
EDUCATION LEVEL
< High School	da	da	da	da	77	72	18	18	76	69
High School Graduate	da	da	da	da	141	131	27	29	141	129
Some College/Associate’s Degree	da	da	da	da	154	113	31	47	153	105
College Graduate	da	da	da	da	96	95	15	20	96	93
EMPLOYMENT STATUS
Full-Time	da	da	da	da	148	125	30	41	144	115
Part-Time	da	da	da	da	68	89	22	24	64	86
Unemployed	da	da	da	da	100	68	16	23	99	64
Other¹	da	da	da	da	148	134	22	33	146	129
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Central nervous system stimulant use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.8D – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.09	0.08	0.14	0.12	0.09	0.08	0.13	0.18	0.10	0.09
SEX
Male	0.14	0.13	0.17	0.19	0.15	0.14	0.20	0.25	0.18	0.16
Female	0.09	0.09	0.21	0.16	0.09	0.10	0.18	0.24	0.11	0.10
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.10	0.09	0.16	0.14	0.10	0.10	0.16	0.20	0.11	0.11
AIAN	2.02	0.49	0.66	0.55	2.44	0.56	2.13	0.61	2.78	0.62
Asian	0.14	0.16	0.22	0.85	0.15	0.15	0.48	0.58	0.15	0.15
Black or African American	0.22	0.15	0.12	0.03	0.24	0.17	0.21	0.36	0.28	0.19
NHPI	*	0.57	*	*	*	0.61	*	0.01	*	0.70
White	0.12	0.11	0.23	0.18	0.12	0.12	0.22	0.26	0.13	0.13
Two or More Races	0.37	0.70	0.60	0.39	0.42	0.83	0.62	0.59	0.51	1.05
Hispanic or Latino	0.19	0.16	0.27	0.20	0.22	0.18	0.25	0.35	0.26	0.21
EDUCATION LEVEL
< High School	da	da	da	da	0.31	0.30	0.49	0.51	0.36	0.34
High School Graduate	da	da	da	da	0.20	0.19	0.24	0.24	0.24	0.22
Some College/Associate’s Degree	da	da	da	da	0.20	0.14	0.23	0.35	0.24	0.16
College Graduate	da	da	da	da	0.11	0.11	0.26	0.34	0.12	0.11
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.12	0.10	0.21	0.29	0.13	0.11
Part-Time	da	da	da	da	0.21	0.27	0.27	0.28	0.27	0.36
Unemployed	da	da	da	da	0.85	0.52	0.47	0.62	1.18	0.68
Other¹	da	da	da	da	0.16	0.14	0.26	0.38	0.17	0.15
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Central nervous system stimulant use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.8P – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.6849	0.2094	0.8177	0.0175	0.3991
SEX
Male	0.8587	0.6222	0.9001	0.0850	0.6180
Female	0.6518	0.2040	0.8255	0.0985	0.4490
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7730	0.4738	0.8410	0.1374	0.5723
AIAN	0.0527	0.7345	0.0532	0.1376	0.0744
Asian	0.5843	0.1958	0.9184	0.6902	0.9056
Black or African American	0.4930	0.0414	0.5520	0.2285	0.3886
NHPI	*	*	*	*	*
White	0.9193	0.4570	0.9972	0.2428	0.7755
Two or More Races	0.0491	0.2118	0.0301	0.5126	0.0384
Hispanic or Latino	0.7637	0.1922	0.9373	0.0233	0.4559
EDUCATION LEVEL
< High School	da	da	0.5093	0.9222	0.5115
High School Graduate	da	da	0.4255	0.1806	0.5941
Some College/Associate’s Degree	da	da	0.3672	0.0371	0.1166
College Graduate	da	da	0.8205	0.4515	0.9225
EMPLOYMENT STATUS
Full-Time	da	da	0.6175	0.0494	0.2847
Part-Time	da	da	0.7118	0.5262	0.5642
Unemployed	da	da	0.2820	0.4568	0.1976
Other¹	da	da	0.6630	0.0343	0.9931
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Central nervous system stimulant use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.9C – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)	Aged 12-20¹ (2023)	Aged 12-20¹ (2024)	Aged 21+¹ (2023)	Aged 21+¹ (2024)
TOTAL	579	582	59	59	574	578	164	149	543	555	120	100	640	650
SEX
Male	453	451	36	30	447	452	114	114	435	441	75	68	497	492
Female	345	345	46	49	340	343	107	102	314	325	85	71	350	363
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	525	520	45	49	526	517	127	123	505	496	102	83	583	589
AIAN	36	24	2	2	36	24	8	9	36	22	3	6	36	23
Asian	121	137	7	*	121	137	45	38	113	127	30	23	119	135
Black or African American	201	212	12	17	200	211	54	50	192	195	34	28	197	208
NHPI	28	28	<1	1	28	28	*	*	25	25	1	*	28	27
White	465	472	43	45	532	544	134	125	503	511	87	72	525	537
Two or More Races	88	83	7	11	87	82	31	25	81	77	26	13	84	81
Hispanic or Latino	242	245	38	30	241	241	88	86	225	231	55	55	261	261
EDUCATION LEVEL
< High School	da	da	da	da	166	150	45	43	173	149	da	da	180	156
High School Graduate	da	da	da	da	291	285	86	92	304	282	da	da	310	292
Some College/Associate’s Degree	da	da	da	da	334	325	137	121	330	321	da	da	350	340
College Graduate	da	da	da	da	311	370	67	80	340	398	da	da	353	413
EMPLOYMENT STATUS
Full-Time	da	da	da	da	473	451	113	122	445	428	da	da	467	447
Part-Time	da	da	da	da	203	201	101	82	174	181	da	da	190	196
Unemployed	da	da	da	da	137	147	54	54	129	137	da	da	136	145
Other²	da	da	da	da	330	354	77	65	322	348	da	da	326	352
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.9D – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)	Aged 12-20¹ (2023)	Aged 12-20¹ (2024)	Aged 21+¹ (2023)	Aged 21+¹ (2024)
TOTAL	0.20	0.20	0.23	0.23	0.22	0.22	0.48	0.43	0.24	0.24	0.29	0.25	0.23	0.23
SEX
Male	0.33	0.32	0.27	0.22	0.36	0.35	0.67	0.65	0.40	0.40	0.36	0.33	0.37	0.37
Female	0.24	0.23	0.37	0.38	0.26	0.25	0.63	0.59	0.27	0.28	0.44	0.36	0.26	0.26
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.23	0.22	0.23	0.26	0.25	0.24	0.49	0.47	0.27	0.26	0.33	0.28	0.25	0.25
AIAN	2.51	1.57	0.66	0.73	3.04	1.83	5.31	4.81	3.48	2.01	1.06	2.15	3.19	1.89
Asian	0.68	0.71	0.47	*	0.74	0.76	1.88	1.49	0.81	0.83	1.23	0.92	0.77	0.80
Black or African American	0.53	0.51	0.33	0.47	0.59	0.57	1.03	0.94	0.67	0.63	0.63	0.52	0.61	0.59
NHPI	2.50	2.26	0.42	1.17	2.73	2.43	*	*	2.83	2.45	0.47	*	2.83	2.46
White	0.27	0.28	0.32	0.34	0.30	0.30	0.61	0.60	0.32	0.32	0.42	0.36	0.31	0.31
Two or More Races	1.32	1.21	0.79	1.02	1.53	1.43	2.45	1.99	1.84	1.72	1.79	0.88	1.61	1.53
Hispanic or Latino	0.46	0.45	0.56	0.44	0.53	0.50	1.06	0.98	0.60	0.59	0.54	0.53	0.57	0.53
EDUCATION LEVEL
< High School	da	da	da	da	0.68	0.62	1.15	1.12	0.76	0.69	da	da	0.73	0.67
High School Graduate	da	da	da	da	0.42	0.41	0.68	0.70	0.48	0.47	da	da	0.45	0.43
Some College/Associate’s Degree	da	da	da	da	0.43	0.42	0.86	0.78	0.48	0.47	da	da	0.45	0.43
College Graduate	da	da	da	da	0.36	0.41	1.00	1.18	0.37	0.43	da	da	0.36	0.41
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.35	0.34	0.71	0.74	0.37	0.37	da	da	0.35	0.35
Part-Time	da	da	da	da	0.61	0.59	1.06	0.85	0.73	0.73	da	da	0.66	0.65
Unemployed	da	da	da	da	1.08	1.04	1.47	1.31	1.43	1.35	da	da	1.21	1.16
Other²	da	da	da	da	0.34	0.34	0.80	0.74	0.36	0.37	da	da	0.35	0.35
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.9P – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)	Aged 12-20¹ (2023)	Aged 21+¹ (2023)
TOTAL	0.0715	0.8354	0.0609	0.2900	0.0957	0.3540	0.0925
SEX
Male	0.4627	0.7526	0.4522	0.9534	0.4297	0.5641	0.4988
Female	0.0427	0.6377	0.0326	0.1063	0.0817	0.4471	0.0549
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0577	0.6406	0.0485	0.0948	0.0986	0.2086	0.0849
AIAN	0.5562	0.4869	0.5333	0.7618	0.4662	0.4917	0.4505
Asian	0.8656	*	0.8682	0.0816	0.6847	0.3835	1.0000
Black or African American	0.9924	0.2849	0.9040	0.4364	0.9424	0.7299	0.9693
NHPI	1.0000	0.3886	0.9638	*	0.8294	*	0.8094
White	0.1129	0.8057	0.1033	0.5226	0.1235	0.5596	0.1299
Two or More Races	0.0439	0.9378	0.0506	0.2380	0.0966	0.0382	0.1280
Hispanic or Latino	0.9107	0.7746	0.9087	0.6807	0.7649	0.8063	0.8560
EDUCATION LEVEL
< High School	da	da	0.1011	0.7171	0.1022	da	0.0863
High School Graduate	da	da	0.4901	0.6128	0.3608	da	0.5589
Some College/Associate’s Degree	da	da	0.9514	0.1013	0.6177	da	0.8166
College Graduate	da	da	0.0851	0.8303	0.0824	da	0.0863
EMPLOYMENT STATUS
Full-Time	da	da	0.1036	0.3309	0.0498	da	0.0805
Part-Time	da	da	0.2472	0.0133	0.8635	da	0.4228
Unemployed	da	da	0.6256	0.3393	0.8925	da	0.6783
Other²	da	da	0.7869	0.7464	0.8548	da	0.9875
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.10C – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	768	805	97	91	756	795	199	191	702	756
SEX
Male	580	619	63	59	570	615	146	137	534	596
Female	464	483	74	69	452	478	128	132	420	449
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	692	720	73	77	688	711	164	161	651	675
AIAN	49	42	4	3	49	42	*	11	46	37
Asian	178	167	18	21	177	166	55	49	168	155
Black or African American	304	305	31	32	296	298	85	85	280	270
NHPI	*	37	1	1	*	37	*	*	*	34
White	573	630	70	69	730	785	191	175	668	729
Two or More Races	108	116	16	18	107	115	41	41	99	107
Hispanic or Latino	311	309	62	49	304	305	108	99	277	288
EDUCATION LEVEL
< High School	da	da	da	da	218	221	66	64	234	229
High School Graduate	da	da	da	da	433	411	130	129	483	436
Some College/Associate’s Degree	da	da	da	da	433	418	193	169	443	450
College Graduate	da	da	da	da	363	415	86	104	419	473
EMPLOYMENT STATUS
Full-Time	da	da	da	da	620	600	156	168	575	562
Part-Time	da	da	da	da	258	285	132	122	214	248
Unemployed	da	da	da	da	201	208	74	77	183	186
Other¹	da	da	da	da	507	522	108	92	490	509
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.10D – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.27	0.28	0.37	0.35	0.29	0.30	0.59	0.55	0.31	0.33
SEX
Male	0.42	0.44	0.47	0.45	0.45	0.48	0.86	0.78	0.49	0.54
Female	0.32	0.33	0.58	0.54	0.34	0.36	0.75	0.76	0.36	0.38
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.30	0.31	0.38	0.40	0.32	0.33	0.64	0.61	0.35	0.36
AIAN	3.21	2.60	1.64	1.38	3.86	3.02	*	5.42	4.26	3.17
Asian	0.97	0.83	1.20	1.31	1.05	0.90	2.20	1.81	1.18	0.99
Black or African American	0.72	0.69	0.79	0.85	0.79	0.75	1.44	1.37	0.91	0.83
NHPI	*	2.96	1.02	1.17	*	3.19	*	*	*	3.39
White	0.34	0.37	0.50	0.52	0.36	0.40	0.74	0.74	0.39	0.43
Two or More Races	1.61	1.54	1.67	1.64	1.87	1.82	2.83	2.97	2.25	2.17
Hispanic or Latino	0.59	0.57	0.91	0.71	0.67	0.64	1.30	1.13	0.75	0.74
EDUCATION LEVEL
< High School	da	da	da	da	0.89	0.92	1.50	1.56	1.00	1.02
High School Graduate	da	da	da	da	0.62	0.58	0.90	0.88	0.71	0.68
Some College/Associate’s Degree	da	da	da	da	0.56	0.54	1.06	0.96	0.62	0.60
College Graduate	da	da	da	da	0.42	0.46	1.22	1.38	0.44	0.47
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.42	0.43	0.87	0.91	0.45	0.46
Part-Time	da	da	da	da	0.75	0.78	1.19	1.13	0.89	0.94
Unemployed	da	da	da	da	1.46	1.30	1.88	1.67	1.90	1.65
Other¹	da	da	da	da	0.49	0.48	1.04	0.99	0.52	0.52
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.10P – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4042	0.2155	0.4690	0.1214	0.6943
SEX
Male	0.9047	0.9450	0.8671	0.3303	0.9514
Female	0.2147	0.0855	0.3133	0.2185	0.4641
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4416	0.6847	0.4489	0.1225	0.6513
AIAN	0.3375	0.5663	0.3087	*	0.3718
Asian	0.6950	0.9393	0.6929	0.2221	0.9668
Black or African American	0.7204	0.8586	0.6799	0.4174	0.8571
NHPI	*	0.7874	*	*	*
White	0.8774	0.6618	0.8950	0.4393	0.9785
Two or More Races	0.4507	0.7372	0.5275	0.8049	0.5580
Hispanic or Latino	0.7773	0.1066	0.9872	0.6462	0.8917
EDUCATION LEVEL
< High School	da	da	0.2499	0.3800	0.3307
High School Graduate	da	da	0.7600	0.1644	0.9741
Some College/Associate’s Degree	da	da	0.4858	0.3077	0.2766
College Graduate	da	da	0.2530	0.6730	0.1992
EMPLOYMENT STATUS
Full-Time	da	da	0.1003	0.8971	0.0838
Part-Time	da	da	0.7524	0.0053	0.4021
Unemployed	da	da	0.6861	0.6803	0.7858
Other¹	da	da	0.4125	0.9136	0.3942
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.11C – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	615	655	88	85	601	640	176	175	548	603
GEOGRAPHIC REGION
Northeast	253	283	29	30	248	279	71	62	232	272
Midwest	243	260	35	32	236	255	66	76	219	236
South	349	413	53	55	346	404	105	100	324	376
West	340	302	49	46	328	297	100	100	286	279
COUNTY TYPE
Large Metro	529	569	78	66	508	557	149	155	461	519
Small Metro	419	392	49	52	403	380	144	135	333	333
Nonmetro	254	288	23	28	247	281	81	71	217	246
Urbanized	157	207	15	14	153	204	61	57	131	175
Less Urbanized	199	195	16	24	195	189	55	42	172	169
Completely Rural	60	46	14	6	51	44	13	7	47	44
POVERTY LEVEL¹
Less Than 100%	302	324	34	38	298	318	98	99	277	293
100-199%	324	310	44	45	318	303	112	94	279	278
200% or More	473	507	75	62	455	496	142	146	414	456
HEALTH INSURANCE²
Private	457	464	72	61	437	453	144	155	400	422
Medicaid/CHIP	402	370	62	60	386	361	127	95	334	340
Other³	333	307	18	13	331	306	56	53	326	300
No Coverage	204	208	12	21	203	206	58	77	192	183
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.11D – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.22	0.23	0.34	0.33	0.23	0.24	0.52	0.50	0.25	0.27
GEOGRAPHIC REGION
Northeast	0.52	0.57	0.72	0.74	0.55	0.61	1.24	1.05	0.59	0.68
Midwest	0.42	0.44	0.64	0.59	0.45	0.48	0.92	1.05	0.48	0.51
South	0.32	0.37	0.51	0.53	0.35	0.40	0.80	0.74	0.38	0.43
West	0.51	0.44	0.80	0.75	0.54	0.48	1.25	1.21	0.54	0.52
COUNTY TYPE
Large Metro	0.29	0.31	0.49	0.43	0.31	0.33	0.68	0.71	0.33	0.36
Small Metro	0.39	0.37	0.56	0.58	0.42	0.39	0.97	0.83	0.43	0.42
Nonmetro	0.51	0.70	0.64	0.84	0.55	0.76	1.32	1.31	0.59	0.80
Urbanized	0.75	1.20	1.16	1.22	0.80	1.28	2.04	2.06	0.85	1.37
Less Urbanized	0.75	0.89	0.78	1.26	0.83	0.96	1.99	1.70	0.90	1.03
Completely Rural	1.21	1.45	3.04	2.23	1.27	1.58	3.74	2.26	1.32	1.77
POVERTY LEVEL¹
Less Than 100%	0.59	0.60	0.58	0.64	0.67	0.68	0.89	1.00	0.80	0.80
100-199%	0.52	0.50	0.78	0.79	0.57	0.54	1.21	0.98	0.62	0.61
200% or More	0.23	0.25	0.46	0.40	0.24	0.26	0.70	0.70	0.25	0.28
HEALTH INSURANCE²
Private	0.24	0.24	0.47	0.39	0.25	0.26	0.61	0.68	0.27	0.28
Medicaid/CHIP	0.55	0.55	0.53	0.56	0.64	0.65	1.07	0.94	0.72	0.76
Other³	0.39	0.37	1.26	0.92	0.40	0.38	1.70	1.69	0.41	0.39
No Coverage	0.78	0.77	0.94	1.66	0.82	0.80	1.17	1.34	0.98	0.92
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.11P – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.5217	0.5438	0.4621	0.7846	0.4000
GEOGRAPHIC REGION
Northeast	0.5635	0.0931	0.6909	0.3518	0.8668
Midwest	0.2064	0.1050	0.1369	0.6760	0.1414
South	0.3315	0.7705	0.3468	0.9575	0.3115
West	0.7567	0.5342	0.6697	0.9558	0.6425
COUNTY TYPE
Large Metro	0.5426	0.1025	0.3851	0.2019	0.5592
Small Metro	0.6223	0.4447	0.5287	0.1349	0.8257
Nonmetro	0.1645	0.4718	0.1922	0.2624	0.0984
Urbanized	0.5173	1.0000	0.5018	0.3254	0.3803
Less Urbanized	0.1154	0.1808	0.1726	0.6228	0.1212
Completely Rural	0.5725	0.3725	0.6752	0.1878	0.8920
POVERTY LEVEL¹
Less Than 100%	0.4777	0.5175	0.5784	0.8792	0.5675
100-199%	0.5126	0.9359	0.5049	0.1990	0.2789
200% or More	1.0000	0.2684	0.8659	0.5871	0.9912
HEALTH INSURANCE²
Private	0.7727	0.1459	0.5995	0.7058	0.5213
Medicaid/CHIP	0.4007	0.9905	0.4015	0.1488	0.1669
Other³	0.2675	0.0877	0.3063	0.3735	0.3836
No Coverage	0.4492	0.0256	0.5999	0.0223	0.7842
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.12C – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)	Aged 12-20¹ (2023)	Aged 12-20¹ (2024)	Aged 21+¹ (2023)	Aged 21+¹ (2024)
TOTAL	579	582	59	59	574	578	164	149	543	555	120	100	640	650
GEOGRAPHIC REGION
Northeast	243	266	20	23	243	266	65	58	235	253	51	33	273	296
Midwest	237	253	27	24	236	247	63	62	230	243	51	44	233	292
South	372	357	36	38	372	353	106	100	349	333	70	69	419	388
West	279	277	29	29	278	281	89	85	274	269	63	53	321	343
COUNTY TYPE
Large Metro	502	534	38	48	498	533	152	137	460	498	91	74	484	526
Small Metro	385	351	43	32	378	346	114	112	358	317	68	58	377	337
Nonmetro	219	192	21	21	217	189	66	68	192	167	42	44	204	180
Urbanized	124	143	14	8	124	142	45	58	110	117	28	29	116	134
Less Urbanized	169	130	16	19	166	126	47	37	144	114	30	33	154	120
Completely Rural	65	44	4	3	65	43	12	11	63	41	6	7	65	42
POVERTY LEVEL²
Less Than 100%	230	265	31	22	228	263	109	92	199	250	68	55	217	257
100-199%	271	233	24	26	269	231	84	87	244	207	44	44	263	226
200% or More	559	541	47	49	554	537	128	119	531	512	82	71	550	529
HEALTH INSURANCE³
Private	522	507	40	48	516	504	152	135	486	468	90	76	507	497
Medicaid/CHIP	256	288	43	36	250	284	80	74	237	266	65	53	243	281
Other⁴	317	272	12	7	317	271	49	47	312	266	31	22	314	270
No Coverage	192	183	11	11	191	181	61	68	178	165	25	38	188	174
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.12D – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)	Aged 12-20¹ (2023)	Aged 12-20¹ (2024)	Aged 21+¹ (2023)	Aged 21+¹ (2024)
TOTAL	0.20	0.20	0.23	0.23	0.22	0.22	0.48	0.43	0.24	0.24	0.29	0.25	0.23	0.23
GEOGRAPHIC REGION
Northeast	0.50	0.53	0.50	0.57	0.54	0.58	1.14	0.98	0.60	0.64	0.78	0.53	0.55	0.60
Midwest	0.41	0.43	0.49	0.44	0.45	0.46	0.89	0.86	0.50	0.53	0.56	0.53	0.46	0.48
South	0.34	0.32	0.35	0.37	0.38	0.35	0.81	0.74	0.41	0.38	0.45	0.43	0.39	0.36
West	0.42	0.41	0.48	0.47	0.46	0.45	1.11	1.03	0.52	0.50	0.65	0.55	0.47	0.48
COUNTY TYPE
Large Metro	0.27	0.29	0.25	0.32	0.30	0.32	0.69	0.61	0.33	0.35	0.40	0.34	0.31	0.33
Small Metro	0.37	0.32	0.50	0.37	0.40	0.35	0.81	0.75	0.45	0.39	0.51	0.43	0.42	0.36
Nonmetro	0.48	0.46	0.59	0.67	0.53	0.49	1.16	1.20	0.56	0.53	0.74	0.84	0.53	0.51
Urbanized	0.71	0.79	1.10	0.75	0.77	0.85	1.51	1.92	0.83	0.89	1.30	1.28	0.77	0.88
Less Urbanized	0.69	0.58	0.77	1.10	0.76	0.62	1.86	1.53	0.79	0.68	1.00	1.24	0.75	0.64
Completely Rural	1.68	1.30	1.31	1.26	1.87	1.40	3.77	3.07	2.08	1.63	1.49	1.69	1.92	1.53
POVERTY LEVEL²
Less Than 100%	0.48	0.51	0.53	0.40	0.54	0.57	1.00	0.92	0.61	0.70	0.71	0.57	0.57	0.61
100-199%	0.46	0.40	0.45	0.47	0.51	0.43	0.98	0.94	0.55	0.47	0.54	0.51	0.52	0.45
200% or More	0.26	0.26	0.30	0.32	0.28	0.28	0.63	0.59	0.31	0.30	0.35	0.33	0.29	0.29
HEALTH INSURANCE³
Private	0.28	0.25	0.28	0.32	0.30	0.28	0.65	0.59	0.32	0.30	0.40	0.35	0.31	0.29
Medicaid/CHIP	0.39	0.43	0.39	0.34	0.46	0.51	0.79	0.76	0.54	0.60	0.41	0.36	0.49	0.55
Other⁴	0.38	0.33	0.86	0.54	0.39	0.34	1.54	1.52	0.40	0.34	1.20	0.88	0.39	0.34
No Coverage	0.75	0.69	0.86	0.89	0.79	0.72	1.21	1.20	0.92	0.85	0.91	1.23	0.82	0.75
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.12P – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)	Aged 12-20¹ (2023)	Aged 21+¹ (2023)
TOTAL	0.0715	0.8354	0.0609	0.2900	0.0957	0.3540	0.0925
GEOGRAPHIC REGION
Northeast	0.1757	0.7030	0.1598	0.0147	0.3906	0.2710	0.2296
Midwest	0.8135	0.3389	0.7442	0.4921	0.6220	0.4293	0.7058
South	0.0299	0.4900	0.0236	0.7539	0.0120	0.8852	0.0267
West	0.8606	0.9155	0.8878	0.9795	0.8826	0.6538	0.8119
COUNTY TYPE
Large Metro	0.4884	0.3385	0.4311	0.3239	0.6164	0.2991	0.5962
Small Metro	0.0081	0.3668	0.0087	0.3996	0.0136	0.2662	0.0114
Nonmetro	0.6942	0.6726	0.7706	0.4714	0.9726	0.1706	0.9180
Urbanized	0.7184	0.3265	0.6526	0.3237	0.9758	0.6541	0.7665
Less Urbanized	0.8743	0.2214	0.9524	0.9364	0.9276	0.1641	0.8416
Completely Rural	0.8834	0.9655	0.9077	0.7899	0.8706	0.8041	0.9004
POVERTY LEVEL²
Less Than 100%	0.8230	0.7835	0.8642	0.4237	0.5938	0.4708	0.7225
100-199%	0.3379	0.7121	0.2989	0.6617	0.2917	0.3428	0.2450
200% or More	0.0714	0.8370	0.0687	0.5469	0.0870	0.1675	0.1075
HEALTH INSURANCE³
Private	0.1431	0.7566	0.1417	0.0839	0.2794	0.1455	0.2267
Medicaid/CHIP	0.4522	0.7892	0.3881	0.5067	0.5027	0.6314	0.4790
Other⁴	0.2205	0.3946	0.2311	0.4022	0.2839	0.1399	0.2710
No Coverage	0.8369	0.7787	0.7834	0.4771	0.5759	0.1095	0.6344
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.13C – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	768	805	97	91	756	795	199	191	702	756
GEOGRAPHIC REGION
Northeast	316	329	32	35	311	327	81	76	297	314
Midwest	300	325	39	34	298	315	76	83	282	301
South	461	526	60	58	458	518	127	118	432	485
West	407	348	54	50	395	347	109	108	361	324
COUNTY TYPE
Large Metro	749	785	84	76	726	775	198	190	657	714
Small Metro	573	538	61	55	557	525	181	176	484	454
Nonmetro	364	350	29	30	356	342	110	96	310	299
Urbanized	213	252	17	16	208	248	84	79	177	206
Less Urbanized	279	247	22	25	274	239	73	56	235	216
Completely Rural	114	64	15	6	105	62	17	13	99	60
POVERTY LEVEL¹
Less Than 100%	373	403	44	39	368	398	149	129	331	372
100-199%	398	383	48	48	393	377	131	118	348	340
200% or More	750	751	83	71	729	743	176	170	683	688
HEALTH INSURANCE²
Private	692	686	79	71	671	676	203	195	628	619
Medicaid/CHIP	473	456	71	62	457	447	143	111	399	420
Other³	437	404	21	14	436	403	65	62	430	396
No Coverage	259	259	16	23	258	256	76	88	240	231
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.13D – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.27	0.28	0.37	0.35	0.29	0.30	0.59	0.55	0.31	0.33
GEOGRAPHIC REGION
Northeast	0.65	0.66	0.78	0.85	0.69	0.72	1.40	1.28	0.76	0.79
Midwest	0.52	0.55	0.71	0.63	0.56	0.59	1.07	1.14	0.62	0.65
South	0.42	0.47	0.59	0.57	0.46	0.51	0.97	0.87	0.50	0.55
West	0.61	0.51	0.87	0.81	0.65	0.56	1.35	1.31	0.68	0.60
COUNTY TYPE
Large Metro	0.36	0.38	0.51	0.48	0.39	0.41	0.80	0.77	0.42	0.45
Small Metro	0.48	0.44	0.67	0.61	0.52	0.48	1.07	0.96	0.56	0.51
Nonmetro	0.66	0.75	0.75	0.89	0.73	0.81	1.62	1.53	0.77	0.87
Urbanized	0.95	1.23	1.30	1.39	1.01	1.31	2.33	2.36	1.06	1.40
Less Urbanized	0.94	0.99	1.00	1.28	1.04	1.07	2.54	2.00	1.08	1.19
Completely Rural	2.43	1.77	2.73	2.57	2.64	1.94	4.49	3.71	2.87	2.25
POVERTY LEVEL¹
Less Than 100%	0.70	0.70	0.73	0.66	0.79	0.78	1.19	1.14	0.92	0.96
100-199%	0.62	0.60	0.85	0.83	0.68	0.66	1.33	1.19	0.75	0.73
200% or More	0.32	0.33	0.49	0.45	0.35	0.36	0.77	0.75	0.37	0.38
HEALTH INSURANCE²
Private	0.33	0.33	0.49	0.46	0.36	0.35	0.75	0.76	0.39	0.38
Medicaid/CHIP	0.62	0.62	0.60	0.57	0.73	0.72	1.14	1.03	0.82	0.86
Other³	0.49	0.47	1.44	1.02	0.50	0.48	1.87	1.85	0.52	0.49
No Coverage	0.94	0.92	1.22	1.82	1.00	0.96	1.44	1.38	1.18	1.14
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.13P – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4042	0.2155	0.4690	0.1214	0.6943
GEOGRAPHIC REGION
Northeast	0.1525	0.1376	0.1906	0.0246	0.4260
Midwest	0.5519	0.0225	0.3976	0.7793	0.3400
South	0.3150	0.6326	0.3324	0.5005	0.3869
West	0.7313	0.4767	0.8209	0.9199	0.7936
COUNTY TYPE
Large Metro	0.7736	0.1594	0.9128	0.8495	0.9710
Small Metro	0.0605	0.5313	0.0615	0.0576	0.1462
Nonmetro	0.2491	0.5849	0.2960	0.4678	0.2217
Urbanized	0.4539	0.8316	0.4589	0.4894	0.4142
Less Urbanized	0.2547	0.3519	0.3348	0.7639	0.2685
Completely Rural	0.6973	0.3239	0.7594	0.3488	0.8865
POVERTY LEVEL¹
Less Than 100%	0.6689	0.9576	0.7496	0.3599	0.4978
100-199%	0.9943	0.7599	1.0000	0.1237	0.6793
200% or More	0.1783	0.1330	0.2446	0.7523	0.2500
HEALTH INSURANCE²
Private	0.3828	0.1721	0.4947	0.0824	0.7616
Medicaid/CHIP	0.8505	0.5089	0.7918	0.0358	0.3639
Other³	0.2579	0.0764	0.2923	0.2333	0.3809
No Coverage	0.9646	0.0419	0.8512	0.1107	0.4500
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.14C – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	272	--	234	--	145	--	185	--	382
12-20²	--	55	--	37	--	28	--	32	--	71
21 or Older²	--	272	--	231	--	140	--	184	--	385
12-17	--	48	--	28	--	23	--	25	--	57
12-13	--	17	--	5	--	1	--	14	--	22
14-15	--	24	--	17	--	10	--	15	--	32
16-17	--	34	--	22	--	20	--	14	--	38
18 or Older	--	268	--	231	--	142	--	185	--	379
18-25	--	53	--	47	--	31	--	33	--	71
18-20	--	25	--	25	--	15	--	18	--	38
21-25	--	45	--	37	--	27	--	27	--	59
26 or Older	--	261	--	226	--	139	--	181	--	365
26-49	--	161	--	134	--	89	--	105	--	219
26-29	--	58	--	45	--	21	--	26	--	77
30-34	--	69	--	58	--	37	--	57	--	101
35-39	--	87	--	70	--	52	--	43	--	107
40-44	--	75	--	65	--	34	--	55	--	109
45-49	--	84	--	81	--	55	--	36	--	108
50 or Older	--	193	--	184	--	113	--	147	--	288
50-54	--	71	--	71	--	54	--	109	--	137
55-59	--	107	--	123	--	80	--	49	--	153
60-64	--	102	--	79	--	40	--	70	--	142
65 or Older	--	88	--	82	--	42	--	56	--	128
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. ² The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.14D – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	0.09	--	0.08	--	0.05	--	0.06	--	0.13
12-20²	--	0.14	--	0.10	--	0.07	--	0.08	--	0.18
21 or Older²	--	0.11	--	0.09	--	0.06	--	0.07	--	0.15
12-17	--	0.18	--	0.11	--	0.09	--	0.09	--	0.22
12-13	--	0.21	--	0.06	--	0.01	--	0.17	--	0.27
14-15	--	0.26	--	0.19	--	0.11	--	0.17	--	0.34
16-17	--	0.38	--	0.25	--	0.23	--	0.16	--	0.42
18 or Older	--	0.10	--	0.09	--	0.05	--	0.07	--	0.14
18-25	--	0.15	--	0.13	--	0.09	--	0.09	--	0.20
18-20	--	0.20	--	0.19	--	0.12	--	0.14	--	0.29
21-25	--	0.20	--	0.17	--	0.12	--	0.12	--	0.26
26 or Older	--	0.12	--	0.10	--	0.06	--	0.08	--	0.16
26-49	--	0.15	--	0.13	--	0.08	--	0.10	--	0.21
26-29	--	0.32	--	0.25	--	0.12	--	0.15	--	0.42
30-34	--	0.29	--	0.24	--	0.16	--	0.24	--	0.42
35-39	--	0.37	--	0.30	--	0.22	--	0.19	--	0.46
40-44	--	0.33	--	0.29	--	0.15	--	0.24	--	0.47
45-49	--	0.43	--	0.41	--	0.29	--	0.19	--	0.55
50 or Older	--	0.16	--	0.15	--	0.09	--	0.12	--	0.24
50-54	--	0.36	--	0.36	--	0.28	--	0.54	--	0.68
55-59	--	0.55	--	0.62	--	0.41	--	0.25	--	0.77
60-64	--	0.45	--	0.35	--	0.18	--	0.31	--	0.62
65 or Older	--	0.15	--	0.14	--	0.07	--	0.09	--	0.21
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. ² The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.15C – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	382	--	57	--	379	--	71	--	365
SEX
Male	--	282	--	34	--	280	--	47	--	274
Female	--	240	--	46	--	238	--	50	--	228
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	351	--	48	--	348	--	57	--	337
AIAN	--	38	--	5	--	38	--	3	--	38
Asian	--	47	--	12	--	45	--	7	--	45
Black or African American	--	140	--	23	--	135	--	27	--	129
NHPI	--	15	--	1	--	15	--	1	--	15
White	--	308	--	38	--	312	--	48	--	305
Two or More Races	--	38	--	15	--	35	--	14	--	33
Hispanic or Latino	--	137	--	29	--	134	--	41	--	131
EDUCATION LEVEL
< High School	da	da	da	da	--	127	--	23	--	125
High School Graduate	da	da	da	da	--	218	--	43	--	221
Some College/Associate’s Degree	da	da	da	da	--	197	--	44	--	193
College Graduate	da	da	da	da	--	158	--	25	--	161
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	220	--	38	--	217
Part-Time	da	da	da	da	--	122	--	34	--	117
Unemployed	da	da	da	da	--	89	--	25	--	86
Other¹	da	da	da	da	--	259	--	42	--	252
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.15D – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.13	--	0.22	--	0.14	--	0.20	--	0.16
SEX
Male	--	0.20	--	0.26	--	0.22	--	0.27	--	0.25
Female	--	0.16	--	0.36	--	0.18	--	0.29	--	0.19
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.15	--	0.25	--	0.16	--	0.22	--	0.18
AIAN	--	2.55	--	2.55	--	3.02	--	2.16	--	3.42
Asian	--	0.25	--	0.82	--	0.26	--	0.29	--	0.30
Black or African American	--	0.38	--	0.61	--	0.41	--	0.57	--	0.46
NHPI	--	1.14	--	1.39	--	1.21	--	0.80	--	1.38
White	--	0.18	--	0.29	--	0.19	--	0.27	--	0.21
Two or More Races	--	0.59	--	1.42	--	0.65	--	1.19	--	0.78
Hispanic or Latino	--	0.25	--	0.41	--	0.28	--	0.47	--	0.34
EDUCATION LEVEL
< High School	da	da	da	da	--	0.53	--	0.64	--	0.60
High School Graduate	da	da	da	da	--	0.31	--	0.34	--	0.37
Some College/Associate’s Degree	da	da	da	da	--	0.25	--	0.32	--	0.29
College Graduate	da	da	da	da	--	0.18	--	0.41	--	0.19
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.17	--	0.27	--	0.19
Part-Time	da	da	da	da	--	0.37	--	0.38	--	0.49
Unemployed	da	da	da	da	--	0.67	--	0.65	--	0.92
Other¹	da	da	da	da	--	0.26	--	0.49	--	0.28
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.16C – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	272	--	234	--	145	--	185	--	382
SEX
Male	--	202	--	195	--	134	--	130	--	282
Female	--	169	--	123	--	64	--	131	--	240
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	254	--	217	--	140	--	168	--	351
AIAN	--	21	--	32	--	11	--	13	--	38
Asian	--	25	--	34	--	17	--	25	--	47
Black or African American	--	83	--	75	--	47	--	89	--	140
NHPI	--	8	--	14	--	*	--	1	--	15
White	--	233	--	200	--	130	--	140	--	308
Two or More Races	--	30	--	20	--	13	--	16	--	38
Hispanic or Latino	--	89	--	84	--	47	--	78	--	137
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.16D – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	0.09	--	0.08	--	0.05	--	0.06	--	0.13
SEX
Male	--	0.14	--	0.14	--	0.09	--	0.09	--	0.20
Female	--	0.11	--	0.08	--	0.04	--	0.09	--	0.16
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.11	--	0.09	--	0.06	--	0.07	--	0.15
AIAN	--	1.50	--	2.23	--	0.81	--	0.92	--	2.55
Asian	--	0.13	--	0.18	--	0.09	--	0.13	--	0.25
Black or African American	--	0.23	--	0.21	--	0.13	--	0.25	--	0.38
NHPI	--	0.63	--	1.06	--	*	--	0.10	--	1.14
White	--	0.14	--	0.12	--	0.08	--	0.08	--	0.18
Two or More Races	--	0.47	--	0.32	--	0.20	--	0.25	--	0.59
Hispanic or Latino	--	0.16	--	0.15	--	0.09	--	0.14	--	0.25
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.17C – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	294	--	40	--	290	--	63	--	281
SEX
Male	--	240	--	19	--	238	--	44	--	234
Female	--	165	--	34	--	162	--	42	--	154
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	269	--	36	--	265	--	52	--	259
AIAN	--	15	--	*	--	15	--	*	--	*
Asian	--	33	--	*	--	31	--	4	--	31
Black or African American	--	89	--	15	--	87	--	24	--	83
NHPI	--	*	--	*	--	*	--	*	--	*
White	--	248	--	30	--	246	--	43	--	242
Two or More Races	--	29	--	*	--	28	--	12	--	27
Hispanic or Latino	--	102	--	15	--	100	--	32	--	94
EDUCATION LEVEL
< High School	da	da	da	da	--	99	--	20	--	95
High School Graduate	da	da	da	da	--	176	--	35	--	174
Some College/Associate’s Degree	da	da	da	da	--	143	--	38	--	137
College Graduate	da	da	da	da	--	121	--	23	--	118
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	173	--	35	--	170
Part-Time	da	da	da	da	--	91	--	29	--	87
Unemployed	da	da	da	da	--	69	--	22	--	65
Other¹	da	da	da	da	--	190	--	34	--	185
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.17D – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.54	--	1.80	--	0.56	--	0.66	--	0.67
SEX
Male	--	0.76	--	2.15	--	0.78	--	0.88	--	0.93
Female	--	0.76	--	2.65	--	0.80	--	0.93	--	0.98
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.60	--	2.19	--	0.62	--	0.72	--	0.73
AIAN	--	4.52	--	*	--	4.72	--	*	--	*
Asian	--	2.01	--	*	--	1.96	--	1.28	--	2.43
Black or African American	--	1.30	--	4.85	--	1.36	--	1.86	--	1.65
NHPI	--	*	--	*	--	*	--	*	--	*
White	--	0.74	--	2.66	--	0.76	--	0.85	--	0.90
Two or More Races	--	1.99	--	*	--	2.11	--	3.13	--	2.78
Hispanic or Latino	--	1.16	--	2.71	--	1.21	--	1.44	--	1.57
EDUCATION LEVEL
< High School	da	da	da	da	--	2.17	--	2.08	--	2.69
High School Graduate	da	da	da	da	--	1.18	--	1.06	--	1.52
Some College/Associate’s Degree	da	da	da	da	--	0.87	--	1.04	--	1.07
College Graduate	da	da	da	da	--	0.81	--	1.44	--	0.91
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.70	--	0.81	--	0.83
Part-Time	da	da	da	da	--	1.37	--	1.28	--	1.97
Unemployed	da	da	da	da	--	1.78	--	1.93	--	2.44
Other¹	da	da	da	da	--	1.26	--	1.83	--	1.42
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.18C – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	272	--	234	--	145	--	185	--	382
GEOGRAPHIC REGION
Northeast	--	135	--	79	--	61	--	52	--	156
Midwest	--	123	--	102	--	57	--	92	--	169
South	--	132	--	146	--	83	--	140	--	220
West	--	142	--	137	--	91	--	64	--	187
COUNTY TYPE
Large Metro	--	201	--	206	--	122	--	146	--	308
Small Metro	--	140	--	94	--	61	--	104	--	191
Nonmetro	--	122	--	67	--	52	--	63	--	146
Urbanized	--	46	--	32	--	22	--	55	--	80
Less Urbanized	--	112	--	57	--	46	--	31	--	124
Completely Rural	--	16	--	16	--	4	--	9	--	25
POVERTY LEVEL²
Less Than 100%	--	174	--	117	--	92	--	105	--	219
100-199%	--	123	--	97	--	65	--	110	--	184
200% or More	--	167	--	181	--	97	--	102	--	250
HEALTH INSURANCE³
Private	--	167	--	183	--	93	--	133	--	271
Medicaid/CHIP	--	209	--	139	--	107	--	144	--	272
Other⁴	--	147	--	142	--	102	--	111	--	217
No Coverage	--	57	--	52	--	37	--	23	--	73
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.18D – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	0.09	--	0.08	--	0.05	--	0.06	--	0.13
GEOGRAPHIC REGION
Northeast	--	0.27	--	0.16	--	0.12	--	0.11	--	0.31
Midwest	--	0.21	--	0.17	--	0.10	--	0.16	--	0.29
South	--	0.12	--	0.13	--	0.07	--	0.13	--	0.20
West	--	0.21	--	0.20	--	0.13	--	0.09	--	0.27
COUNTY TYPE
Large Metro	--	0.12	--	0.12	--	0.07	--	0.09	--	0.18
Small Metro	--	0.15	--	0.10	--	0.07	--	0.11	--	0.20
Nonmetro	--	0.33	--	0.19	--	0.14	--	0.18	--	0.39
Urbanized	--	0.28	--	0.22	--	0.15	--	0.38	--	0.50
Less Urbanized	--	0.59	--	0.31	--	0.25	--	0.17	--	0.63
Completely Rural	--	0.54	--	0.47	--	0.14	--	0.34	--	0.70
POVERTY LEVEL²
Less Than 100%	--	0.35	--	0.24	--	0.20	--	0.23	--	0.43
100-199%	--	0.22	--	0.17	--	0.12	--	0.20	--	0.32
200% or More	--	0.09	--	0.10	--	0.05	--	0.05	--	0.13
HEALTH INSURANCE³
Private	--	0.09	--	0.10	--	0.05	--	0.07	--	0.15
Medicaid/CHIP	--	0.33	--	0.23	--	0.18	--	0.24	--	0.42
Other⁴	--	0.19	--	0.18	--	0.13	--	0.14	--	0.27
No Coverage	--	0.23	--	0.21	--	0.15	--	0.09	--	0.29
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.19C – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Substance for Which Treatment Was Received¹	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT²	--	162	--	33	--	158	--	38	--	153
DRUGS	--	126	--	26	--	122	--	28	--	119
Marijuana	--	59	--	16	--	56	--	25	--	51
Cocaine	--	45	--	*	--	44	--	10	--	43
Heroin	--	75	--	1	--	75	--	10	--	74
Hallucinogens	--	27	--	7	--	26	--	15	--	21
Inhalants	--	21	--	*	--	14	--	6	--	12
Methamphetamine	--	68	--	<1	--	68	--	16	--	66
Prescription Psychotherapeutics	--	74	--	12	--	72	--	15	--	71
Pain Relievers	--	60	--	10	--	59	--	12	--	57
Stimulants	--	26	--	7	--	25	--	10	--	23
Tranquilizers or Sedatives	--	61	--	5	--	61	--	9	--	60
Tranquilizers	--	61	--	*	--	60	--	9	--	60
Sedatives	--	35	--	3	--	35	--	6	--	34
Opioids	--	95	--	10	--	94	--	15	--	92
Central Nervous System Stimulants	--	81	--	10	--	80	--	20	--	77
ALCOHOL	--	86	--	17	--	84	--	22	--	82
BOTH DRUGS AND ALCOHOL	--	53	--	12	--	52	--	16	--	49
*SUBSTANCE UNSPECIFIED²*	--	75	--	17	--	74	--	21	--	71
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive. ² Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance(s) for which they received treatment. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.19D – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Standard Errors of Percentages, 2023 and 2024
Substance for Which Treatment Was Received¹	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT²	--	0.00	--	0.00	--	0.00	--	0.00	--	0.00
DRUGS	--	3.12	--	5.99	--	3.41	--	5.38	--	3.89
Marijuana	--	2.04	--	5.31	--	2.18	--	5.88	--	2.31
Cocaine	--	1.61	--	*	--	1.79	--	2.73	--	2.05
Heroin	--	2.65	--	0.22	--	2.93	--	2.91	--	3.41
Hallucinogens	--	1.03	--	2.58	--	1.10	--	3.83	--	1.07
Inhalants	--	0.82	--	*	--	0.58	--	1.56	--	0.63
Methamphetamine	--	2.36	--	0.08	--	2.63	--	4.11	--	2.97
Prescription Psychotherapeutics	--	2.47	--	4.15	--	2.73	--	3.80	--	3.14
Pain Relievers	--	2.13	--	3.50	--	2.35	--	3.24	--	2.70
Stimulants	--	0.98	--	2.38	--	1.06	--	2.71	--	1.15
Tranquilizers or Sedatives	--	2.15	--	1.80	--	2.39	--	2.38	--	2.77
Tranquilizers	--	2.15	--	*	--	2.39	--	2.37	--	2.77
Sedatives	--	1.32	--	0.99	--	1.46	--	1.63	--	1.70
Opioids	--	3.03	--	3.51	--	3.35	--	4.18	--	3.80
Central Nervous System Stimulants	--	2.69	--	3.38	--	2.98	--	4.84	--	3.38
ALCOHOL	--	2.67	--	5.58	--	2.91	--	5.33	--	3.35
BOTH DRUGS AND ALCOHOL	--	1.88	--	4.10	--	2.05	--	4.22	--	2.25
*SUBSTANCE UNSPECIFIED²*	--	2.52	--	5.37	--	2.76	--	4.96	--	3.15
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive. ² Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance(s) for which they received treatment. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.20C – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Substance for Which Treatment Was Received¹	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT²	--	337	--	43	--	334	--	59	--	325
DRUGS	--	212	--	32	--	210	--	45	--	202
Marijuana	--	90	--	19	--	88	--	32	--	81
Cocaine	--	64	--	*	--	64	--	8	--	63
Heroin	--	78	--	*	--	78	--	10	--	77
Hallucinogens	--	35	--	13	--	33	--	17	--	28
Inhalants	--	35	--	13	--	32	--	4	--	32
Methamphetamine	--	109	--	*	--	109	--	17	--	109
Prescription Psychotherapeutics	--	156	--	23	--	154	--	25	--	149
Pain Relievers	--	142	--	20	--	141	--	19	--	138
Stimulants	--	42	--	7	--	41	--	12	--	39
Tranquilizers or Sedatives	--	71	--	10	--	70	--	17	--	68
Tranquilizers	--	67	--	9	--	66	--	16	--	64
Sedatives	--	40	--	5	--	40	--	7	--	39
Opioids	--	152	--	21	--	151	--	20	--	148
Central Nervous System Stimulants	--	123	--	10	--	122	--	22	--	121
ALCOHOL	--	169	--	22	--	167	--	32	--	164
BOTH DRUGS AND ALCOHOL	--	107	--	18	--	105	--	23	--	102
*SUBSTANCE UNSPECIFIED²*	--	194	--	22	--	193	--	31	--	192
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive. ² Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance(s) for which they received treatment. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.20D – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Standard Errors of Percentages, 2023 and 2024
Substance for Which Treatment Was Received¹	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT²	--	0.00	--	0.00	--	0.00	--	0.00	--	0.00
DRUGS	--	2.14	--	3.94	--	2.27	--	3.90	--	2.52
Marijuana	--	1.22	--	3.73	--	1.28	--	3.54	--	1.33
Cocaine	--	0.86	--	*	--	0.92	--	1.07	--	1.03
Heroin	--	1.05	--	*	--	1.13	--	1.34	--	1.27
Hallucinogens	--	0.50	--	2.68	--	0.49	--	2.24	--	0.47
Inhalants	--	0.49	--	2.68	--	0.48	--	0.57	--	0.54
Methamphetamine	--	1.43	--	*	--	1.53	--	2.21	--	1.72
Prescription Psychotherapeutics	--	1.85	--	4.07	--	1.95	--	3.11	--	2.12
Pain Relievers	--	1.73	--	3.71	--	1.83	--	2.45	--	2.01
Stimulants	--	0.59	--	1.44	--	0.61	--	1.61	--	0.66
Tranquilizers or Sedatives	--	0.98	--	2.23	--	1.03	--	2.14	--	1.14
Tranquilizers	--	0.92	--	2.00	--	0.97	--	2.06	--	1.07
Sedatives	--	0.56	--	1.04	--	0.59	--	0.90	--	0.66
Opioids	--	1.83	--	3.75	--	1.94	--	2.55	--	2.15
Central Nervous System Stimulants	--	1.55	--	2.05	--	1.64	--	2.63	--	1.85
ALCOHOL	--	1.91	--	4.17	--	2.03	--	3.60	--	2.23
BOTH DRUGS AND ALCOHOL	--	1.40	--	3.66	--	1.48	--	2.88	--	1.62
*SUBSTANCE UNSPECIFIED²*	--	2.07	--	3.67	--	2.22	--	3.60	--	2.47
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive. ² Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance(s) for which they received treatment. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.21C – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Received MAUD (2023)	Received MAUD (2024)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2024)
TOTAL	129	141	71	104
AGE GROUP
12-17	5	16	2	14
18 or Older	129	140	71	103
18-25	17	23	15	20
26 or Older	128	138	69	100
SEX
Male	81	122	51	88
Female	101	69	49	50
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	122	126	67	96
AIAN	*	8	<1	2
Asian	7	4	*	*
Black or African American	27	51	9	20
NHPI	<1	1	*	*
White	118	115	66	94
Two or More Races	6	7	5	6
Hispanic or Latino	41	57	22	32
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.21D – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Received MAUD (2023)	Received MAUD (2024)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2024)
TOTAL	0.05	0.05	0.24	0.37
AGE GROUP
12-17	0.02	0.06	0.22	1.75
18 or Older	0.05	0.05	0.25	0.37
18-25	0.05	0.06	0.29	0.41
26 or Older	0.06	0.06	0.30	0.45
SEX
Male	0.06	0.09	0.30	0.52
Female	0.07	0.05	0.40	0.44
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.05	0.05	0.27	0.41
AIAN	*	0.57	0.05	1.49
Asian	0.04	0.02	*	*
Black or African American	0.08	0.14	0.28	0.59
NHPI	0.03	0.08	*	*
White	0.07	0.07	0.34	0.52
Two or More Races	0.09	0.10	0.59	1.04
Hispanic or Latino	0.08	0.10	0.46	0.64
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.21P – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Received MAUD (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)
TOTAL	0.4672	0.2152
AGE GROUP
12-17	0.0237	0.0264
18 or Older	0.5929	0.3042
18-25	0.2575	0.2342
26 or Older	0.7050	0.4102
SEX
Male	0.0723	0.0740
Female	0.2931	0.6552
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6061	0.3384
AIAN	*	0.0636
Asian	0.4973	*
Black or African American	0.0370	0.1312
NHPI	0.6219	*
White	0.9183	0.5005
Two or More Races	0.8392	0.5539
Hispanic or Latino	0.4606	0.2143
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.22C – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Received MOUD (2023)	Received MOUD (2024)	Received MOUD among People with an Opioid Use Disorder¹ (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2024)
TOTAL	183	165	129	95
AGE GROUP
12-17	12	10	*	7
18 or Older	183	164	129	95
18-25	21	13	11	11
26 or Older	182	162	129	94
SEX
Male	132	117	105	66
Female	129	111	75	66
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	167	159	110	89
AIAN	5	18	*	*
Asian	10	12	*	*
Black or African American	42	56	*	22
NHPI	1	*	*	*
White	161	144	105	85
Two or More Races	11	15	*	*
Hispanic or Latino	86	42	*	32
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.22D – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Received MOUD (2023)	Received MOUD (2024)	Received MOUD among People with an Opioid Use Disorder¹ (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2024)
TOTAL	0.06	0.06	2.32	1.84
AGE GROUP
12-17	0.05	0.04	*	2.56
18 or Older	0.07	0.06	2.42	1.95
18-25	0.06	0.04	3.22	3.12
26 or Older	0.08	0.07	2.59	2.11
SEX
Male	0.10	0.08	3.70	2.74
Female	0.09	0.08	2.72	2.46
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.07	0.07	2.42	2.08
AIAN	0.38	1.27	*	*
Asian	0.06	0.07	*	*
Black or African American	0.12	0.16	*	4.34
NHPI	0.14	*	*	*
White	0.09	0.08	2.99	2.56
Two or More Races	0.17	0.23	*	*
Hispanic or Latino	0.16	0.08	*	3.77
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.22P – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Received MOUD (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2023)
TOTAL	0.4648	0.2929
AGE GROUP
12-17	0.9180	*
18 or Older	0.4588	0.3044
18-25	0.1754	0.7946
26 or Older	0.5516	0.2923
SEX
Male	0.9617	0.5105
Female	0.2755	0.3857
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8442	0.3784
AIAN	0.4018	*
Asian	0.8747	*
Black or African American	0.2319	*
NHPI	*	*
White	0.5121	0.2495
Two or More Races	0.3496	*
Hispanic or Latino	0.1952	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.23C – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received MAUD (2023)	Received MAUD (2024)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2024)
TOTAL	129	141	71	104
GEOGRAPHIC REGION
Northeast	55	58	32	57
Midwest	41	52	33	33
South	98	92	31	55
West	48	77	45	60
COUNTY TYPE
Large Metro	103	133	42	96
Small Metro	73	45	54	33
Nonmetro	30	31	20	12
Urbanized	17	9	8	5
Less Urbanized	24	29	17	11
Completely Rural	7	3	*	*
POVERTY LEVEL²
Less Than 100%	52	55	43	28
100-199%	45	62	21	35
200% or More	111	114	53	91
HEALTH INSURANCE³
Private	94	119	30	93
Medicaid/CHIP	79	62	58	31
Other⁴	58	83	27	47
No Coverage	25	19	16	15
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.23D – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received MAUD (2023)	Received MAUD (2024)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2024)
TOTAL	0.05	0.05	0.24	0.37
GEOGRAPHIC REGION
Northeast	0.11	0.12	0.61	1.16
Midwest	0.07	0.09	0.54	0.53
South	0.09	0.08	0.29	0.54
West	0.07	0.11	0.64	0.86
COUNTY TYPE
Large Metro	0.07	0.08	0.25	0.57
Small Metro	0.08	0.05	0.56	0.39
Nonmetro	0.08	0.09	0.65	0.43
Urbanized	0.11	0.06	0.65	0.38
Less Urbanized	0.13	0.16	1.10	0.76
Completely Rural	0.24	0.10	*	*
POVERTY LEVEL²
Less Than 100%	0.11	0.12	0.98	0.63
100-199%	0.08	0.11	0.44	0.76
200% or More	0.06	0.06	0.27	0.48
HEALTH INSURANCE³
Private	0.05	0.07	0.17	0.53
Medicaid/CHIP	0.13	0.10	0.96	0.57
Other⁴	0.07	0.10	0.52	0.98
No Coverage	0.10	0.08	0.52	0.48
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.23P – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Received MAUD (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)
TOTAL	0.4672	0.2152
GEOGRAPHIC REGION
Northeast	0.8913	0.1483
Midwest	0.5870	0.5088
South	0.5687	0.1495
West	0.3582	0.9726
COUNTY TYPE
Large Metro	0.1072	0.0244
Small Metro	0.1812	0.3729
Nonmetro	0.5828	0.1677
Urbanized	0.4184	0.9895
Less Urbanized	0.9800	0.2239
Completely Rural	0.4270	*
POVERTY LEVEL²
Less Than 100%	0.6278	0.5523
100-199%	0.2872	0.1303
200% or More	0.8771	0.2625
HEALTH INSURANCE³
Private	0.0805	0.0027
Medicaid/CHIP	0.1259	0.0122
Other⁴	0.1870	0.1299
No Coverage	0.8113	0.4486
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.24C – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received MOUD (2023)	Received MOUD (2024)	Received MOUD among People with an Opioid Use Disorder¹ (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2024)
TOTAL	183	165	129	95
GEOGRAPHIC REGION
Northeast	87	80	46	45
Midwest	69	65	40	40
South	105	93	72	49
West	104	92	*	56
COUNTY TYPE
Large Metro	133	108	107	60
Small Metro	90	105	50	56
Nonmetro	89	66	54	51
Urbanized	59	25	21	6
Less Urbanized	65	60	*	*
Completely Rural	12	7	*	*
POVERTY LEVEL²
Less Than 100%	107	93	73	54
100-199%	82	70	58	42
200% or More	125	117	90	67
HEALTH INSURANCE³
Private	126	117	85	66
Medicaid/CHIP	125	112	83	68
Other⁴	101	72	69	31
No Coverage	38	31	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.24D – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received MOUD (2023)	Received MOUD (2024)	Received MOUD among People with an Opioid Use Disorder¹ (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2024)
TOTAL	0.06	0.06	2.32	1.84
GEOGRAPHIC REGION
Northeast	0.18	0.16	5.44	5.43
Midwest	0.12	0.11	4.14	3.60
South	0.10	0.08	3.00	2.51
West	0.16	0.14	*	4.36
COUNTY TYPE
Large Metro	0.08	0.07	3.74	2.39
Small Metro	0.10	0.11	2.91	3.40
Nonmetro	0.23	0.19	5.26	4.91
Urbanized	0.38	0.17	4.88	2.26
Less Urbanized	0.33	0.34	*	*
Completely Rural	0.40	0.25	*	*
POVERTY LEVEL²
Less Than 100%	0.23	0.20	4.17	3.20
100-199%	0.15	0.13	4.66	3.31
200% or More	0.07	0.06	3.46	3.04
HEALTH INSURANCE³
Private	0.07	0.07	3.81	3.25
Medicaid/CHIP	0.20	0.19	3.63	2.92
Other⁴	0.13	0.09	3.14	1.70
No Coverage	0.16	0.12	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.24P – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Received MOUD (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2023)
TOTAL	0.4648	0.2929
GEOGRAPHIC REGION
Northeast	0.8261	0.8217
Midwest	0.1492	0.8273
South	0.8750	0.8318
West	0.6653	*
COUNTY TYPE
Large Metro	0.9770	0.0713
Small Metro	0.8289	0.1849
Nonmetro	0.0667	0.4167
Urbanized	0.0224	0.1664
Less Urbanized	0.4895	*
Completely Rural	0.7403	*
POVERTY LEVEL²
Less Than 100%	0.5086	0.7000
100-199%	0.5837	0.1294
200% or More	0.8324	0.8360
HEALTH INSURANCE³
Private	0.7527	0.7026
Medicaid/CHIP	0.6723	0.7755
Other⁴	0.4538	0.1118
No Coverage	0.2098	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.25C – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2024)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2024)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2024)
TOTAL	151	135	123	118	205	185
AGE GROUP
12-17	19	18	9	14	19	18
18 or Older	150	133	122	117	204	184
18-25	46	32	37	26	55	41
26 or Older	143	130	117	114	195	179
SEX
Male	119	118	101	87	159	148
Female	103	68	64	77	131	109
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	123	129	103	109	177	173
AIAN	5	7	1	2	5	7
Asian	13	13	17	*	21	24
Black or African American	47	37	29	33	58	48
NHPI	*	*	*	*	*	*
White	109	123	91	102	157	162
Two or More Races	14	12	28	6	29	20
Hispanic or Latino	87	40	66	39	106	58
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.25D – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2024)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2024)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2024)
TOTAL	0.54	0.46	0.41	0.41	0.40	0.37
AGE GROUP
12-17	1.03	1.02	1.23	1.71	0.86	0.89
18 or Older	0.57	0.48	0.42	0.42	0.42	0.38
18-25	0.73	0.51	0.69	0.52	0.57	0.45
26 or Older	0.72	0.61	0.49	0.50	0.51	0.45
SEX
Male	0.76	0.70	0.59	0.51	0.56	0.50
Female	0.84	0.55	0.52	0.67	0.59	0.52
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.54	0.53	0.41	0.47	0.42	0.41
AIAN	2.14	3.31	0.74	1.62	1.63	2.43
Asian	1.76	1.83	1.72	*	1.34	1.47
Black or African American	1.15	0.91	0.87	0.96	0.92	0.76
NHPI	*	*	*	*	*	*
White	0.65	0.68	0.47	0.57	0.49	0.51
Two or More Races	1.47	1.10	3.17	0.87	1.84	1.37
Hispanic or Latino	1.81	0.80	1.36	0.78	1.24	0.67
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.25P – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)
TOTAL	0.2537	0.6816	0.1602
AGE GROUP
12-17	0.4952	0.5469	0.4990
18 or Older	0.2828	0.6406	0.1752
18-25	0.5964	0.1893	0.2376
26 or Older	0.3222	0.9081	0.2654
SEX
Male	0.9810	0.3216	0.4597
Female	0.0586	0.5204	0.1904
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6524	0.9853	0.4350
AIAN	0.6384	0.1771	0.5860
Asian	0.8879	*	0.9094
Black or African American	0.8182	0.2301	0.6475
NHPI	*	*	*
White	0.6209	0.9483	0.3299
Two or More Races	0.8719	0.0311	0.6530
Hispanic or Latino	0.1237	0.3890	0.1097
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.26C – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2024)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2024)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2024)
TOTAL	151	135	123	118	205	185
GEOGRAPHIC REGION
Northeast	70	54	60	36	103	68
Midwest	51	61	47	41	69	72
South	80	64	60	74	107	103
West	95	84	72	74	119	113
COUNTY TYPE
Large Metro	137	109	88	104	165	153
Small Metro	57	62	75	46	102	78
Nonmetro	54	55	34	30	74	63
Urbanized	31	23	12	17	36	24
Less Urbanized	45	50	18	25	61	58
Completely Rural	*	*	*	*	*	7
POVERTY LEVEL²
Less Than 100%	87	106	55	39	107	116
100-199%	68	48	29	47	86	65
200% or More	108	77	102	104	153	131
HEALTH INSURANCE³
Private	93	76	77	99	130	126
Medicaid/CHIP	119	112	77	51	150	127
Other⁴	68	94	70	57	110	110
No Coverage	26	27	24	25	35	37
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.26D – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2024)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2024)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2024)
TOTAL	0.54	0.46	0.41	0.41	0.40	0.37
GEOGRAPHIC REGION
Northeast	1.31	1.08	1.14	0.79	1.10	0.80
Midwest	0.90	0.92	0.74	0.64	0.64	0.63
South	0.82	0.61	0.54	0.72	0.57	0.57
West	1.31	1.16	1.02	1.03	0.99	0.89
COUNTY TYPE
Large Metro	0.90	0.67	0.52	0.61	0.58	0.53
Small Metro	0.63	0.67	0.77	0.55	0.62	0.52
Nonmetro	1.43	1.33	1.07	1.02	1.18	1.01
Urbanized	1.93	1.37	0.97	1.28	1.38	0.92
Less Urbanized	2.27	2.17	1.20	1.67	1.93	1.75
Completely Rural	*	*	*	*	*	2.23
POVERTY LEVEL²
Less Than 100%	1.33	1.47	1.23	0.86	1.12	1.14
100-199%	1.08	0.71	0.61	1.01	0.90	0.67
200% or More	0.71	0.49	0.50	0.54	0.49	0.43
HEALTH INSURANCE³
Private	0.69	0.55	0.42	0.55	0.47	0.44
Medicaid/CHIP	1.21	1.12	1.28	0.93	1.10	0.95
Other⁴	1.23	1.80	1.29	1.18	1.12	1.19
No Coverage	0.79	0.72	0.77	0.77	0.65	0.66
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.26P – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)
TOTAL	0.2537	0.6816	0.1602
GEOGRAPHIC REGION
Northeast	0.7953	0.2230	0.1876
Midwest	0.9653	0.7212	0.5953
South	0.6089	0.3525	0.8932
West	0.2615	0.5887	0.2476
COUNTY TYPE
Large Metro	0.0656	0.8310	0.3062
Small Metro	0.4342	0.2460	0.3512
Nonmetro	0.8340	0.8972	0.6949
Urbanized	0.6123	0.8575	0.1691
Less Urbanized	0.7074	0.2453	0.6274
Completely Rural	*	*	*
POVERTY LEVEL²
Less Than 100%	0.7583	0.2705	0.9403
100-199%	0.1156	0.2034	0.2088
200% or More	0.2633	0.6203	0.2060
HEALTH INSURANCE³
Private	0.8566	0.5063	0.8994
Medicaid/CHIP	0.1668	0.1003	0.0510
Other⁴	0.5912	0.6315	0.8332
No Coverage	0.8251	0.4693	0.5892
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.27C – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Type/Location of Treatment or Other Services	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT OR OTHER SERVICES^1,2	--	472	--	61	--	467	--	78	--	457
SUBSTANCE USE TREATMENT¹	--	382	--	57	--	379	--	71	--	365
Inpatient¹	--	160	--	33	--	156	--	38	--	152
Hospital¹	--	106	--	24	--	103	--	33	--	98
Residential Drug or Alcohol Rehab or Treatment Center¹	--	118	--	18	--	117	--	29	--	113
Residential Mental Health Treatment Center¹	--	104	--	23	--	100	--	32	--	95
Some Other Place as an Inpatient¹	--	62	--	17	--	61	--	22	--	57
Outpatient¹	--	329	--	43	--	327	--	58	--	318
Drug or Alcohol Rehab or Treatment Center¹	--	173	--	17	--	172	--	30	--	165
Mental Health Treatment Center¹	--	157	--	18	--	157	--	32	--	150
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional¹	--	256	--	29	--	254	--	49	--	245
General Medical Clinic or Doctor’s Office¹	--	223	--	25	--	224	--	31	--	223
Hospital¹	--	125	--	17	--	123	--	21	--	122
School’s Health or Counseling Center¹	--	85	--	31	--	78	--	23	--	72
Some Other Place as an Outpatient¹	--	79	--	10	--	79	--	19	--	76
Outpatient, Other Than General Medical Clinic or Doctor’s Office¹	--	305	--	41	--	302	--	54	--	292
Medications for Alcohol Use Disorder³	129	141	5	16	129	140	17	23	128	138
Medications for Opioid Use Disorder⁴	183	165	12	10	183	164	21	13	182	162
Telehealth Treatment⁵	227	221	22	22	225	219	56	44	218	213
Prison, Jail, or Juvenile Detention Center	102	119	12	14	101	118	17	14	100	117
OTHER SERVICES
Support Services
Support Group	289	317	29	27	286	314	40	44	286	312
Peer Support Specialist or Recovery Coach	173	177	19	12	170	177	28	23	168	174
Emergency Room/Department or Withdrawal Management Services
Emergency Room/Department	148	146	22	16	146	145	38	34	141	141
Withdrawal Management Services	129	100	15	12	129	99	25	17	126	97
Overdose Reversal Medicine (e.g. Narcan® or Naloxone)	--	156	--	18	--	155	--	27	--	152
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. ³ Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ⁴ Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ⁵ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.27D – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2023 and 2024
Type/Location of Treatment or Other Services	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT OR OTHER SERVICES^1,2	--	0.16	--	0.24	--	0.18	--	0.22	--	0.20
SUBSTANCE USE TREATMENT¹	--	0.13	--	0.22	--	0.14	--	0.20	--	0.16
Inpatient¹	--	0.06	--	0.13	--	0.06	--	0.11	--	0.07
Hospital¹	--	0.04	--	0.09	--	0.04	--	0.09	--	0.04
Residential Drug or Alcohol Rehab or Treatment Center¹	--	0.04	--	0.07	--	0.04	--	0.08	--	0.05
Residential Mental Health Treatment Center¹	--	0.04	--	0.09	--	0.04	--	0.09	--	0.04
Some Other Place as an Inpatient¹	--	0.02	--	0.06	--	0.02	--	0.06	--	0.02
Outpatient¹	--	0.11	--	0.16	--	0.12	--	0.17	--	0.14
Drug or Alcohol Rehab or Treatment Center¹	--	0.06	--	0.07	--	0.07	--	0.09	--	0.07
Mental Health Treatment Center¹	--	0.05	--	0.07	--	0.06	--	0.09	--	0.07
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional¹	--	0.09	--	0.11	--	0.10	--	0.14	--	0.11
General Medical Clinic or Doctor’s Office¹	--	0.08	--	0.10	--	0.09	--	0.09	--	0.10
Hospital¹	--	0.04	--	0.06	--	0.05	--	0.06	--	0.05
School’s Health or Counseling Center¹	--	0.03	--	0.12	--	0.03	--	0.07	--	0.03
Some Other Place as an Outpatient¹	--	0.03	--	0.04	--	0.03	--	0.05	--	0.03
Outpatient, Other Than General Medical Clinic or Doctor’s Office¹	--	0.11	--	0.16	--	0.12	--	0.16	--	0.13
Medications for Alcohol Use Disorder³	0.05	0.05	0.02	0.06	0.05	0.05	0.05	0.06	0.06	0.06
Medications for Opioid Use Disorder⁴	0.06	0.06	0.05	0.04	0.07	0.06	0.06	0.04	0.08	0.07
Telehealth Treatment⁵	0.08	0.08	0.08	0.09	0.09	0.08	0.16	0.13	0.10	0.09
Prison, Jail, or Juvenile Detention Center	0.04	0.04	0.05	0.05	0.04	0.04	0.05	0.04	0.04	0.05
OTHER SERVICES
Support Services
Support Group	0.10	0.11	0.11	0.10	0.11	0.12	0.12	0.13	0.13	0.14
Peer Support Specialist or Recovery Coach	0.06	0.06	0.07	0.05	0.07	0.07	0.08	0.07	0.08	0.08
Emergency Room/Department or Withdrawal Management Services
Emergency Room/Department	0.05	0.05	0.09	0.06	0.06	0.06	0.11	0.10	0.06	0.06
Withdrawal Management Services	0.05	0.03	0.06	0.05	0.05	0.04	0.07	0.05	0.06	0.04
Overdose Reversal Medicine (e.g. Narcan® or Naloxone)	--	0.05	--	0.07	--	0.06	--	0.08	--	0.07
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. ³ Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ⁴ Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ⁵ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.27P – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Type/Location of Treatment or Other Services	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
SUBSTANCE USE TREATMENT OR OTHER SERVICES^1,2	--	--	--	--	--
SUBSTANCE USE TREATMENT¹	--	--	--	--	--
Inpatient¹	--	--	--	--	--
Hospital¹	--	--	--	--	--
Residential Drug or Alcohol Rehab or Treatment Center¹	--	--	--	--	--
Residential Mental Health Treatment Center¹	--	--	--	--	--
Some Other Place as an Inpatient¹	--	--	--	--	--
Outpatient¹	--	--	--	--	--
Drug or Alcohol Rehab or Treatment Center¹	--	--	--	--	--
Mental Health Treatment Center¹	--	--	--	--	--
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional¹	--	--	--	--	--
General Medical Clinic or Doctor’s Office¹	--	--	--	--	--
Hospital¹	--	--	--	--	--
School’s Health or Counseling Center¹	--	--	--	--	--
Some Other Place as an Outpatient¹	--	--	--	--	--
Outpatient, Other Than General Medical Clinic or Doctor’s Office¹	--	--	--	--	--
Medications for Alcohol Use Disorder³	0.4672	0.0237	0.5929	0.2575	0.7050
Medications for Opioid Use Disorder⁴	0.4648	0.9180	0.4588	0.1754	0.5516
Telehealth Treatment⁵	0.1996	0.1986	0.2378	0.1566	0.3819
Prison, Jail, or Juvenile Detention Center	0.9547	0.9433	0.9503	0.5463	0.8823
OTHER SERVICES
Support Services
Support Group	0.7074	0.7092	0.6885	0.3604	0.7820
Peer Support Specialist or Recovery Coach	0.8459	0.1539	0.9418	0.6593	1.0000
Emergency Room/Department or Withdrawal Management Services
Emergency Room/Department	0.4408	0.2541	0.5266	0.5226	0.6211
Withdrawal Management Services	0.1524	0.3406	0.1817	0.1781	0.2694
Overdose Reversal Medicine (e.g. Narcan® or Naloxone)	--	--	--	--	--
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. ³ Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ⁴ Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ⁵ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.28C – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Substance for Which Treatment Was Received and Use Disorder for Specific Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER¹	--	142	--	21	--	139	--	30	--	135
DRUGS	--	108	--	16	--	105	--	23	--	103
Marijuana	--	45	--	14	--	42	--	20	--	38
Cocaine	--	16	--	*	--	16	--	7	--	14
Heroin	--	*	--	*	--	*	--	*	--	*
Hallucinogens	--	11	--	*	--	9	--	*	--	*
Inhalants	--	2	--	*	--	*	--	*	--	*
Methamphetamine	--	44	--	*	--	44	--	*	--	42
Prescription Psychotherapeutics	--	53	--	5	--	53	--	11	--	52
Pain Relievers	--	38	--	3	--	38	--	10	--	38
Stimulants	--	14	--	*	--	13	--	7	--	11
Tranquilizers or Sedatives	--	48	--	*	--	47	--	7	--	47
Tranquilizers	--	39	--	*	--	39	--	7	--	38
Sedatives	--	*	--	*	--	*	--	*	--	*
Opioids²	--	70	--	3	--	70	--	12	--	70
Central Nervous System Stimulants	--	49	--	*	--	48	--	17	--	45
ALCOHOL	--	68	--	8	--	67	--	15	--	67
BOTH DRUGS AND ALCOHOL	--	29	--	3	--	29	--	10	--	27
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance(s) for which they received treatment. ² Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.28D – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Standard Errors of Percentages, 2023 and 2024
Substance for Which Treatment Was Received and Use Disorder for Specific Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER¹	--	0.29	--	1.02	--	0.29	--	0.33	--	0.35
DRUGS	--	0.37	--	0.93	--	0.38	--	0.37	--	0.49
Marijuana	--	0.22	--	1.15	--	0.22	--	0.35	--	0.27
Cocaine	--	1.36	--	*	--	1.37	--	2.49	--	1.62
Heroin	--	*	--	*	--	*	--	*	--	*
Hallucinogens	--	2.63	--	*	--	2.71	--	*	--	*
Inhalants	--	0.54	--	*	--	*	--	*	--	*
Methamphetamine	--	2.71	--	*	--	2.73	--	*	--	2.74
Prescription Psychotherapeutics	--	0.68	--	0.95	--	0.73	--	1.31	--	0.81
Pain Relievers	--	0.78	--	1.01	--	0.83	--	2.81	--	0.88
Stimulants	--	0.74	--	*	--	0.79	--	1.63	--	0.91
Tranquilizers or Sedatives	--	2.13	--	*	--	2.24	--	3.02	--	2.51
Tranquilizers	--	2.40	--	*	--	2.53	--	3.71	--	2.86
Sedatives	--	*	--	*	--	*	--	*	--	*
Opioids²	--	1.41	--	1.11	--	1.49	--	3.41	--	1.61
Central Nervous System Stimulants	--	1.09	--	*	--	1.14	--	2.28	--	1.29
ALCOHOL	--	0.24	--	1.10	--	0.25	--	0.30	--	0.30
BOTH DRUGS AND ALCOHOL	--	0.37	--	0.77	--	0.39	--	0.48	--	0.52
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance(s) for which they received treatment. ² Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.29C – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Substance for Which Treatment Was Received and Use Disorder for Specific Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER¹	--	249	--	32	--	246	--	52	--	238
DRUGS	--	163	--	19	--	161	--	40	--	155
Marijuana	--	74	--	15	--	72	--	29	--	66
Cocaine	--	35	--	*	--	35	--	8	--	34
Heroin	--	31	--	*	--	31	--	*	--	30
Hallucinogens	--	17	--	*	--	*	--	*	--	*
Inhalants	--	*	--	*	--	*	--	*	--	*
Methamphetamine	--	53	--	*	--	53	--	*	--	51
Prescription Psychotherapeutics	--	92	--	8	--	91	--	20	--	89
Pain Relievers	--	71	--	4	--	71	--	14	--	69
Stimulants	--	29	--	6	--	28	--	7	--	27
Tranquilizers or Sedatives	--	56	--	*	--	56	--	*	--	55
Tranquilizers	--	45	--	*	--	45	--	*	--	43
Sedatives	--	38	--	*	--	38	--	*	--	*
Opioids²	--	76	--	6	--	76	--	16	--	74
Central Nervous System Stimulants	--	70	--	6	--	70	--	18	--	68
ALCOHOL	--	111	--	16	--	109	--	27	--	105
BOTH DRUGS AND ALCOHOL	--	51	--	9	--	50	--	16	--	47
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance(s) for which they received treatment. ² Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.29D – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Standard Errors of Percentages, 2023 and 2024
Substance for Which Treatment Was Received and Use Disorder for Specific Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER¹	--	0.47	--	1.51	--	0.49	--	0.54	--	0.58
DRUGS	--	0.55	--	1.08	--	0.58	--	0.61	--	0.72
Marijuana	--	0.35	--	1.19	--	0.36	--	0.51	--	0.47
Cocaine	--	2.85	--	*	--	2.88	--	2.80	--	3.68
Heroin	--	4.99	--	*	--	5.04	--	*	--	5.25
Hallucinogens	--	3.78	--	*	--	*	--	*	--	*
Inhalants	--	*	--	*	--	*	--	*	--	*
Methamphetamine	--	3.20	--	*	--	3.21	--	*	--	3.27
Prescription Psychotherapeutics	--	1.14	--	1.60	--	1.21	--	2.34	--	1.34
Pain Relievers	--	1.39	--	1.51	--	1.48	--	3.80	--	1.56
Stimulants	--	1.53	--	3.06	--	1.64	--	1.65	--	2.14
Tranquilizers or Sedatives	--	2.48	--	*	--	2.62	--	*	--	2.90
Tranquilizers	--	2.72	--	*	--	2.87	--	*	--	3.18
Sedatives	--	4.34	--	*	--	4.59	--	*	--	*
Opioids²	--	1.52	--	2.18	--	1.61	--	4.24	--	1.71
Central Nervous System Stimulants	--	1.55	--	2.80	--	1.62	--	2.40	--	1.92
ALCOHOL	--	0.38	--	2.06	--	0.39	--	0.53	--	0.46
BOTH DRUGS AND ALCOHOL	--	0.64	--	2.02	--	0.67	--	0.74	--	0.91
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance(s) for which they received treatment. ² Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.30C – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Drug Use Disorder, Past Year Alcohol Use Disorder, Past Year Drug and Alcohol Use Disorder, and Past Year Substance Use Disorder, Standard Errors of Numbers in Thousands, 2023 and 2024
Substance/Age Group	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
DRUGS	--	204	--	133	--	112	--	110	--	246
12-17	--	30	--	18	--	16	--	17	--	35
18 or Older	--	200	--	131	--	110	--	109	--	242
18-25	--	47	--	36	--	26	--	19	--	58
26 or Older	--	197	--	127	--	109	--	107	--	235
ALCOHOL	--	124	--	162	--	97	--	85	--	201
12-17	--	27	--	21	--	21	--	10	--	29
18 or Older	--	120	--	161	--	94	--	86	--	199
18-25	--	34	--	38	--	27	--	17	--	46
26 or Older	--	113	--	155	--	90	--	84	--	191
BOTH DRUGS AND ALCOHOL	--	94	--	85	--	65	--	70	--	129
12-17	--	23	--	17	--	16	--	10	--	25
18 or Older	--	90	--	83	--	63	--	69	--	126
18-25	--	31	--	31	--	24	--	12	--	38
26 or Older	--	83	--	76	--	57	--	68	--	119
SUBSTANCE USE DISORDER	--	222	--	193	--	135	--	120	--	294
12-17	--	33	--	22	--	21	--	17	--	40
18 or Older	--	217	--	191	--	132	--	120	--	290
18-25	--	49	--	43	--	29	--	23	--	63
26 or Older	--	213	--	187	--	131	--	118	--	281
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.30D – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Drug Use Disorder, Past Year Alcohol Use Disorder, Past Year Drug and Alcohol Use Disorder, and Past Year Substance Use Disorder, Standard Errors of Percentages, 2023 and 2024
Substance/Age Group	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
DRUGS	--	0.66	--	0.45	--	0.39	--	0.38	--	0.77
12-17	--	1.68	--	1.00	--	0.93	--	0.97	--	1.90
18 or Older	--	0.69	--	0.48	--	0.40	--	0.40	--	0.81
18-25	--	0.72	--	0.57	--	0.41	--	0.30	--	0.87
26 or Older	--	0.88	--	0.60	--	0.52	--	0.52	--	1.01
ALCOHOL	--	0.42	--	0.55	--	0.34	--	0.30	--	0.66
12-17	--	3.14	--	2.58	--	2.53	--	1.25	--	3.30
18 or Older	--	0.42	--	0.56	--	0.34	--	0.31	--	0.67
18-25	--	0.67	--	0.74	--	0.52	--	0.34	--	0.89
26 or Older	--	0.49	--	0.66	--	0.39	--	0.38	--	0.79
BOTH DRUGS AND ALCOHOL	--	1.12	--	1.03	--	0.82	--	0.88	--	1.46
12-17	--	4.38	--	3.35	--	3.27	--	2.08	--	4.54
18 or Older	--	1.14	--	1.08	--	0.84	--	0.93	--	1.52
18-25	--	1.35	--	1.35	--	1.05	--	0.54	--	1.61
26 or Older	--	1.51	--	1.42	--	1.09	--	1.31	--	2.04
SUBSTANCE USE DISORDER	--	0.43	--	0.38	--	0.27	--	0.24	--	0.54
12-17	--	1.55	--	1.06	--	1.01	--	0.82	--	1.80
18 or Older	--	0.44	--	0.39	--	0.28	--	0.25	--	0.56
18-25	--	0.52	--	0.47	--	0.32	--	0.25	--	0.66
26 or Older	--	0.53	--	0.47	--	0.34	--	0.31	--	0.67
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.31C – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Substance Use Disorder Severity Level/Age Group	Among People Aged 12 or Older with Substance Use Disorder in Past Year
Substance Use Disorder Severity Level/Age Group	Received Substance Use Treatment (SU Tx) (2023)	Received Substance Use Treatment (SU Tx) (2024)	Did Not Receive SU Tx (2023)	Did Not Receive SU Tx (2024)	Received SU Tx or Other Services¹ (2023)	Received SU Tx or Other Services¹ (2024)	Did Not Receive SU Tx or Other Services¹ (2023)	Did Not Receive SU Tx or Other Services¹ (2024)
Any SUD	--	294	--	913	--	334	--	887
12-17	--	40	--	89	--	42	--	88
18 or Older	--	290	--	904	--	329	--	879
18-25	--	63	--	250	--	70	--	248
26 or Older	--	281	--	816	--	320	--	793
Mild SUD	--	168	--	663	--	193	--	657
12-17	--	17	--	63	--	19	--	62
18 or Older	--	166	--	659	--	191	--	652
18-25	--	30	--	171	--	35	--	171
26 or Older	--	163	--	614	--	187	--	609
Moderate SUD	--	150	--	367	--	159	--	361
12-17	--	22	--	40	--	24	--	39
18 or Older	--	148	--	365	--	157	--	359
18-25	--	25	--	116	--	31	--	115
26 or Older	--	145	--	336	--	154	--	330
Severe SUD	--	179	--	294	--	208	--	270
12-17	--	25	--	43	--	26	--	43
18 or Older	--	177	--	291	--	206	--	269
18-25	--	45	--	95	--	49	--	94
26 or Older	--	170	--	271	--	201	--	247
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.31D – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Standard Errors of Percentages, 2023 and 2024
Substance Use Disorder Severity Level/Age Group	Among People Aged 12 or Older with Substance Use Disorder in Past Year
Substance Use Disorder Severity Level/Age Group	Received Substance Use Treatment (SU Tx) (2023)	Received Substance Use Treatment (SU Tx) (2024)	Did Not Receive SU Tx (2023)	Did Not Receive SU Tx (2024)	Received SU Tx or Other Services¹ (2023)	Received SU Tx or Other Services¹ (2024)	Did Not Receive SU Tx or Other Services¹ (2023)	Did Not Receive SU Tx or Other Services¹ (2024)
Any SUD	--	0.54	--	0.54	--	0.60	--	0.60
12-17	--	1.80	--	1.80	--	1.90	--	1.90
18 or Older	--	0.56	--	0.56	--	0.62	--	0.62
18-25	--	0.66	--	0.66	--	0.74	--	0.74
26 or Older	--	0.67	--	0.67	--	0.74	--	0.74
Mild SUD	--	0.59	--	0.59	--	0.67	--	0.67
12-17	--	1.59	--	1.59	--	1.76	--	1.76
18 or Older	--	0.61	--	0.61	--	0.69	--	0.69
18-25	--	0.67	--	0.67	--	0.78	--	0.78
26 or Older	--	0.72	--	0.72	--	0.81	--	0.81
Moderate SUD	--	1.26	--	1.26	--	1.31	--	1.31
12-17	--	3.96	--	3.96	--	4.19	--	4.19
18 or Older	--	1.31	--	1.31	--	1.36	--	1.36
18-25	--	1.01	--	1.01	--	1.22	--	1.22
26 or Older	--	1.65	--	1.65	--	1.72	--	1.72
Severe SUD	--	1.39	--	1.39	--	1.50	--	1.50
12-17	--	4.18	--	4.18	--	4.33	--	4.33
18 or Older	--	1.47	--	1.47	--	1.58	--	1.58
18-25	--	1.88	--	1.88	--	1.99	--	1.99
26 or Older	--	1.82	--	1.82	--	1.96	--	1.96
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.32C – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Among the Total Population		Among People Classified as Needing Substance Use Treatment (SU Tx)
Demographic Characteristic	Classified as Needing SU Tx (2023)	Classified as Needing SU Tx (2024)	% Who Received SU Tx (2023)	% Who Received SU Tx (2024)	% Who Did Not Receive SU Tx (2023)	% Who Did Not Receive SU Tx (2024)	% Who Received SU Tx or Other Services¹ (2023)	% Who Received SU Tx or Other Services¹ (2024)	% Who Did Not Receive SU Tx or Other Services¹ (2023)	% Who Did Not Receive SU Tx or Other Services¹ (2024)
TOTAL	--	842	--	0.64	--	0.64	--	0.67	--	0.67
AGE GROUP
12-17	--	95	--	2.07	--	2.07	--	2.11	--	2.11
18 or Older	--	833	--	0.67	--	0.67	--	0.70	--	0.70
18-25	--	192	--	0.73	--	0.73	--	0.78	--	0.78
26 or Older	--	794	--	0.78	--	0.78	--	0.83	--	0.83
SEX
Male	--	632	--	0.83	--	0.83	--	0.87	--	0.87
Female	--	519	--	0.95	--	0.95	--	1.03	--	1.03
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	756	--	0.70	--	0.70	--	0.73	--	0.73
AIAN	--	55	--	*	--	*	--	*	--	*
Asian	--	172	--	2.61	--	2.61	--	3.30	--	3.30
Black or African American	--	327	--	1.73	--	1.73	--	1.73	--	1.73
NHPI	--	41	--	*	--	*	--	*	--	*
White	--	653	--	0.83	--	0.83	--	0.87	--	0.87
Two or More Races	--	119	--	2.37	--	2.37	--	2.54	--	2.54
Hispanic or Latino	--	328	--	1.37	--	1.37	--	1.54	--	1.54
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.32D – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Among the Total Population		Among People Classified as Needing Substance Use Treatment (SU Tx)
Demographic Characteristic	Classified as Needing SU Tx (2023)	Classified as Needing SU Tx (2024)	% Who Received SU Tx (2023)	% Who Received SU Tx (2024)	% Who Did Not Receive SU Tx (2023)	% Who Did Not Receive SU Tx (2024)	% Who Received SU Tx or Other Services¹ (2023)	% Who Received SU Tx or Other Services¹ (2024)	% Who Did Not Receive SU Tx or Other Services¹ (2023)	% Who Did Not Receive SU Tx or Other Services¹ (2024)
TOTAL	--	0.29	--	0.64	--	0.64	--	0.67	--	0.67
AGE GROUP
12-17	--	0.36	--	2.07	--	2.07	--	2.11	--	2.11
18 or Older	--	0.32	--	0.67	--	0.67	--	0.70	--	0.70
18-25	--	0.55	--	0.73	--	0.73	--	0.78	--	0.78
26 or Older	--	0.35	--	0.78	--	0.78	--	0.83	--	0.83
SEX
Male	--	0.45	--	0.83	--	0.83	--	0.87	--	0.87
Female	--	0.35	--	0.95	--	0.95	--	1.03	--	1.03
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.32	--	0.70	--	0.70	--	0.73	--	0.73
AIAN	--	3.12	--	*	--	*	--	*	--	*
Asian	--	0.84	--	2.61	--	2.61	--	3.30	--	3.30
Black or African American	--	0.73	--	1.73	--	1.73	--	1.73	--	1.73
NHPI	--	3.10	--	*	--	*	--	*	--	*
White	--	0.38	--	0.83	--	0.83	--	0.87	--	0.87
Two or More Races	--	1.58	--	2.37	--	2.37	--	2.54	--	2.54
Hispanic or Latino	--	0.60	--	1.37	--	1.37	--	1.54	--	1.54
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.33C – Classified as Needing Alcohol Use Treatment: Among People Aged 12 or Older; Receipt of Alcohol Use Treatment in Past Year: Among People Aged 12 or Older Classified as Needing Alcohol Use Treatment in Past Year; by Demographic Characteristics, Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Among the Total Population		Among People Classified as Needing Alcohol Use Treatment (ALC Tx)
Demographic Characteristic	Classified as Needing ALC Tx (2023)	Classified as Needing ALC Tx (2024)	% Who Received ALC Tx (2023)	% Who Received ALC Tx (2024)	% Who Did Not Receive ALC Tx (2023)	% Who Did Not Receive ALC Tx (2024)
TOTAL	--	615	--	0.71	--	0.71
AGE GROUP
12-17	--	62	--	2.91	--	2.91
18 or Older	--	610	--	0.72	--	0.72
18-25	--	150	--	0.88	--	0.88
26 or Older	--	587	--	0.86	--	0.86
SEX
Male	--	481	--	0.99	--	0.99
Female	--	361	--	0.97	--	0.97
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	548	--	0.80	--	0.80
AIAN	--	38	--	*	--	*
Asian	--	138	--	3.21	--	3.21
Black or African American	--	223	--	1.86	--	1.86
NHPI	--	33	--	*	--	*
White	--	494	--	0.96	--	0.96
Two or More Races	--	85	--	2.95	--	2.95
Hispanic or Latino	--	251	--	1.51	--	1.51
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing alcohol use treatment if they met DSM-5 criteria for an alcohol use disorder or received treatment for alcohol use. NOTE: Alcohol use treatment includes treatment for alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Alcohol use treatment questions are asked of respondents who used alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.33D – Classified as Needing Alcohol Use Treatment: Among People Aged 12 or Older; Receipt of Alcohol Use Treatment in Past Year: Among People Aged 12 or Older Classified as Needing Alcohol Use Treatment in Past Year; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Among the Total Population		Among People Classified as Needing Alcohol Use Treatment (ALC Tx)
Demographic Characteristic	Classified as Needing ALC Tx (2023)	Classified as Needing ALC Tx (2024)	% Who Received ALC Tx (2023)	% Who Received ALC Tx (2024)	% Who Did Not Receive ALC Tx (2023)	% Who Did Not Receive ALC Tx (2024)
TOTAL	--	0.21	--	0.71	--	0.71
AGE GROUP
12-17	--	0.24	--	2.91	--	2.91
18 or Older	--	0.23	--	0.72	--	0.72
18-25	--	0.43	--	0.88	--	0.88
26 or Older	--	0.26	--	0.86	--	0.86
SEX
Male	--	0.34	--	0.99	--	0.99
Female	--	0.25	--	0.97	--	0.97
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.23	--	0.80	--	0.80
AIAN	--	2.43	--	*	--	*
Asian	--	0.71	--	3.21	--	3.21
Black or African American	--	0.54	--	1.86	--	1.86
NHPI	--	2.53	--	*	--	*
White	--	0.29	--	0.96	--	0.96
Two or More Races	--	1.24	--	2.95	--	2.95
Hispanic or Latino	--	0.46	--	1.51	--	1.51
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing alcohol use treatment if they met DSM-5 criteria for an alcohol use disorder or received treatment for alcohol use. NOTE: Alcohol use treatment includes treatment for alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Alcohol use treatment questions are asked of respondents who used alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.34C – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2023)	Any Perceived Unmet Need (2024)	Sought Treatment (2023)	Sought Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2023)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Perceive Need for Substance Use Treatment (2023)	Did Not Perceive Need for Substance Use Treatment (2024)
TOTAL	--	25	--	13	--	22	--	82
AGE GROUP
12-13	--	3	--	*	--	1	--	27
14-15	--	13	--	8	--	10	--	36
16-17	--	22	--	10	--	19	--	66
SEX
Male	--	19	--	5	--	18	--	54
Female	--	17	--	12	--	12	--	62
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	20	--	12	--	16	--	68
AIAN	--	*	--	*	--	*	--	*
Asian	--	*	--	*	--	*	--	*
Black or African American	--	6	--	*	--	3	--	27
NHPI	--	*	--	*	--	*	--	*
White	--	19	--	11	--	16	--	59
Two or More Races	--	3	--	*	--	1	--	18
Hispanic or Latino	--	15	--	*	--	*	--	44
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.34D – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2023)	Any Perceived Unmet Need (2024)	Sought Treatment (2023)	Sought Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2023)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Perceive Need for Substance Use Treatment (2023)	Did Not Perceive Need for Substance Use Treatment (2024)
TOTAL	--	1.44	--	0.76	--	1.26	--	1.44
AGE GROUP
12-13	--	1.61	--	*	--	0.82	--	1.61
14-15	--	2.78	--	1.83	--	2.18	--	2.78
16-17	--	1.94	--	0.91	--	1.76	--	1.94
SEX
Male	--	2.37	--	0.66	--	2.30	--	2.37
Female	--	1.79	--	1.26	--	1.31	--	1.79
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	1.65	--	0.99	--	1.35	--	1.65
AIAN	--	*	--	*	--	*	--	*
Asian	--	*	--	*	--	*	--	*
Black or African American	--	2.73	--	*	--	1.62	--	2.73
NHPI	--	*	--	*	--	*	--	*
White	--	2.21	--	1.28	--	1.86	--	2.21
Two or More Races	--	2.73	--	*	--	1.48	--	2.73
Hispanic or Latino	--	2.96	--	*	--	*	--	2.96
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.35C – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2023)	Any Perceived Unmet Need (2024)	Sought Treatment (2023)	Sought Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2023)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Perceive Need for Substance Use Treatment (2023)	Did Not Perceive Need for Substance Use Treatment (2024)
TOTAL	--	142	--	73	--	122	--	859
AGE GROUP
18-25	--	50	--	23	--	42	--	241
26 or Older	--	132	--	70	--	113	--	775
26-49	--	88	--	31	--	83	--	522
50 or Older	--	99	--	62	--	77	--	554
SEX
Male	--	104	--	64	--	83	--	622
Female	--	96	--	36	--	89	--	491
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	119	--	46	--	110	--	770
AIAN	--	1	--	1	--	1	--	37
Asian	--	*	--	*	--	*	--	*
Black or African American	--	40	--	12	--	39	--	264
NHPI	--	*	--	*	--	*	--	*
White	--	107	--	43	--	99	--	679
Two or More Races	--	24	--	11	--	21	--	109
Hispanic or Latino	--	77	--	57	--	51	--	316
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.35D – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2023)	Any Perceived Unmet Need (2024)	Sought Treatment (2023)	Sought Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2023)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Perceive Need for Substance Use Treatment (2023)	Did Not Perceive Need for Substance Use Treatment (2024)
TOTAL	--	0.34	--	0.18	--	0.30	--	0.34
AGE GROUP
18-25	--	0.59	--	0.28	--	0.51	--	0.59
26 or Older	--	0.40	--	0.22	--	0.35	--	0.40
26-49	--	0.43	--	0.16	--	0.40	--	0.43
50 or Older	--	0.82	--	0.52	--	0.65	--	0.82
SEX
Male	--	0.43	--	0.27	--	0.35	--	0.43
Female	--	0.57	--	0.22	--	0.53	--	0.57
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.35	--	0.14	--	0.32	--	0.35
AIAN	--	0.59	--	0.27	--	0.53	--	0.59
Asian	--	*	--	*	--	*	--	*
Black or African American	--	0.78	--	0.24	--	0.75	--	0.78
NHPI	--	*	--	*	--	*	--	*
White	--	0.41	--	0.17	--	0.39	--	0.41
Two or More Races	--	1.99	--	0.91	--	1.78	--	1.99
Hispanic or Latino	--	1.09	--	0.82	--	0.73	--	1.09
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.36C – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 18 or Older Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Standard Errors of Numbers in Thousands, 2023 and 2024
Reason for Not Receiving Substance Use Treatment	Total (2023)	Total (2024)
Thought It Would Cost Too Much	--	89
Did Not Have Health Insurance Coverage for Drug or Alcohol Use Treatment	--	71
Health Insurance Would Not Pay Enough of Costs for Treatment	--	63
Did Not Know How or Where to Get Treatment	--	88
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	--	95
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	--	28
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them	--	49
Did Not Have Enough Time for Treatment	--	96
Worried That Information Would Not Be Kept Private	--	76
Worried about What People Would Think or Say if They Got Treatment	--	95
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	--	80
Not Ready to Start Treatment	--	124
Not Ready to Stop or Cut Back Using Drugs or Alcohol	--	116
Thought They Should Have Been Able to Handle Their Drug or Alcohol Use on Their Own	--	128
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	--	75
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will	--	51
Did Not Think Treatment Would Help Them	--	92
Thought No One Would Care if They Got Better	--	53
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving substance use treatment data were excluded. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.36D – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 18 or Older Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Standard Errors of Percentages, 2023 and 2024
Reason for Not Receiving Substance Use Treatment	Total (2023)	Total (2024)
Thought It Would Cost Too Much	--	3.66
Did Not Have Health Insurance Coverage for Drug or Alcohol Use Treatment	--	3.41
Health Insurance Would Not Pay Enough of Costs for Treatment	--	3.14
Did Not Know How or Where to Get Treatment	--	3.65
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	--	3.81
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	--	1.53
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them	--	2.52
Did Not Have Enough Time for Treatment	--	3.71
Worried That Information Would Not Be Kept Private	--	3.44
Worried about What People Would Think or Say if They Got Treatment	--	3.85
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	--	3.56
Not Ready to Start Treatment	--	3.65
Not Ready to Stop or Cut Back Using Drugs or Alcohol	--	3.80
Thought They Should Have Been Able to Handle Their Drug or Alcohol Use on Their Own	--	3.56
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	--	3.33
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will	--	2.51
Did Not Think Treatment Would Help Them	--	3.88
Thought No One Would Care if They Got Better	--	2.58
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving substance use treatment data were excluded. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.